Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Lymphoma, Non-Hodgkin

fluorodeoxyglucose f18 has been researched along with Lymphoma, Non-Hodgkin in 461 studies

Research

Studies (461)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (0.22)	18.7374
1990's	41 (8.89)	18.2507
2000's	197 (42.73)	29.6817
2010's	176 (38.18)	24.3611
2020's	46 (9.98)	2.80

Authors

Authors	Studies
Fujimoto, S; Ishishita, Y; Kawai, K; Koide, R; Mashiko, T; Matsuzono, K; Ohtani, K; Ozawa, T; Tanaka, R; Yagisawa, T; Yamaguchi, T	1
Cheson, BD; Meignan, M	1
Wu, Y; Xiang, XR; Yang, CL	1
Du, B; Hao, W; Li, X; Li, Y	1
Bailly, C; Bodet-Milin, C; Carlier, T; Gastinne, T; Kraeber-Bodere, F; Le Gouill, S; Tessoulin, B	1
Li, J; Liu, Y; Ma, N; Yuan, L; Zhao, M	1
Ansell, SM; Bansal, R; Bennani, NN; Breen, WG; Hathcock, MA; Johnston, PB; Khurana, A; Kowalchuk, RO; Lester, SC; Lin, Y; Paludo, J; Peterson, JL; Villasboas Bisneto, JC; Wang, Y; Young, JR	1
Akashi, K; Baba, S; Iawasaki, H; Ishigami, K; Kamesaki, K; Kato, K; Kikushige, Y; Kunisaki, Y; Miyamoto, T; Miyawaki, K; Mori, Y; Numata, A; Shima, T; Sugio, T; Takashima, S; Takenaka, K; Urata, S; Yoshimoto, G	1
Albader, FL; Elhaggracy, RS; Marafi, F; Usmani, S	1
Choi, JY; Kim, SJ; Lee, KH; Yi, HK; Yoo, J	1
Kang, HJ; Lee, I; Lee, KC; Lim, I; Lim, SM	1
Dührsen, U; Fendler, WP; Ferdinandus, J; Hanoun, C; Herrmann, K; Hüttmann, A; Kersting, D; Rahbar, K; Reinhardt, HC; Rischpler, C; Sandach, P; Schäfers, M; Seifert, R; Umutlu, L; von Tresckow, B; Weckesser, M	1
Giannakopoulos, V; Ilias, I; Meristoudis, G	1
Chen, YJ; Hsieh, CH; Huang, YM; Lee, JC; Tsao, CH; Wang, SY	1
Shen, K; Yang, C	1
Ansell, SM; Bansal, R; Breen, WG; Hathcock, MA; Hoppe, BS; Iqbal, M; Johnston, PB; Kharfan-Dabaja, MA; Khurana, A; Lester, SC; Lin, Y; Moustafa, MA; Munoz, J; Murthy, HS; Paludo, J; Peterson, JL; Rosenthal, A; Rule, WG; Saifi, O; Stish, BJ; Villasboas, JC; Wang, Y	1
He, Y; Li, P; Li, Y; Yang, J; Zhao, W	1
Dai, N; Deng, S; Han, J; Huang, H; Jia, T; Sang, S; Zhang, B; Zhou, Y	1
Cheng, W; Feng, J; He, D; Qi, S; Xu, C; Yue, Y; Zhang, G	1
Hernández-Cruz, M; López-Colombo, A; Montiel-Jarquín, ÁJ; Ruiz-Eng, R; Vargas-Partida, T; Vázquez-Cruz, E	1
Lijun, Z; Xiao-Xue, W; Xinyue, H	1
Bando, Y; Dimitrakopoulou-Strauss, A; Harada, M; Kondo, M; Kubo, M; Otomi, Y; Otomo, M; Shinya, T; Terazawa, K	1
Amoedo, MK; Barbosa, PNV; Dantas, GC; Travesso, DJ; Tyng, CJ	1
Akin, S; Erbaş, B; Eren, G; Kars, A; Kupik, O; Tuncel, M; Türker, A	1
Alessandrino, F; Kalisz, K; Levine, I; Ramaiya, NH; Smith, DA; Tirumani, SH	1
Amarelli, C; Belfiore, MP; Cappabianca, S; Casale, B; Ciccozzi, M; Creta, M; DE Rimini, ML; Maiello, C; Reginelli, A; Sagnelli, C; Sagnelli, E; Sica, A; Spada, A; Troiani, T	1
Cheong, JW; Cho, A; Cho, H; Chung, H; Jang, JE; Kim, JS; Kim, SJ; Kim, Y; Kim, YR; Min, YH; Yang, WI	1
Gallamini, A; Meignan, M	1
Kuang, A; Shen, G	1
Gupta, T; Kannan, S; Manjali, JJ; Purandare, N; Rangarajan, V	2
Li, F; Luo, Y; Pan, Q; Zhang, Y	1
González, E; Martí, A; Morón, S; Rojas, J	1
Blakkisrud, J; Dahle, J; Kolstad, A; Løndalen, A; Madsbu, UE; Revheim, ME; Stokke, C	1
Ge, Y; He, J; Ji, CF; Liu, S; Sun, YW; Wang, H; Zhou, ZY	1
Fan, W; Yuan, J; Zhang, X; Zhou, C	1
Carpenter, B; Castleton, A; Elliot, J; Fielding, AK; Fox, TA; Grandage, V; Halsey, R; Hough, R; Khwaja, A; Mansour, MR; Nicholson, E; Perisoglou, M; Taj, M; Uttenthal, B; Wright, C	1
Bektaş, S; Beyhan, E; Çermik, TF; Ergül, N; Erol, Ö	1
Chen, Y; Tang, W; Wang, Q; Yang, S	1
Bernard, S; Guevara, DL; Manhood, S; Melani, S; Rodríguez, MLÁ; Yerovi, F	1
Choi, JY; Hyun, SH; Kim, SJ; Kim, WS; Lee, JH; Lee, KH; Min, BH; Moon, SH; Park, YJ	1
Altmann, B; Angel, S; Barbato, F; Bewarder, M; Dührsen, U; Grosse, J; Held, G; Hellwig, D; Herrmann, K; Hüttmann, A; Kaddu-Mulindwa, D; Löffler, M; Menhart, K; Pfreundschuh, M; Poeschel, V; Schwier, M; Stilgenbauer, S; Thurner, L; Ziepert, M	1
Francis, JH; Grommes, C; Hatzoglou, V; Krebs, S; Mauguen, A; Mellinghoff, IK; Schaff, LR; Schöder, H; Yildirim, O	1
Baraniskin, A; Frey, AV; Herrlinger, U; Korfel, A; Kowalski, T; Ladigan-Badura, S; Margold, M; Schlegel, U; Schmidt-Wolf, IGH; Schroers, R; Seidel, S	1
Attygalle, A; Chau, I; Cunningham, D; El-Sharkawi, D; Goldman, A; Iyengar, S; Kowa, JY; Li, S; Mackinnon, A; Mahalingam, P; Marshall, K; Millard, T; Nicholson, E; Rich, P; Sharma, B; Sharma, RK; Welsh, L	1
Fujimoto, K; Hoshikawa, H; Ihara-Nishishita, A; Kobata, T; Kudomi, N; Mitamura, K; Nishiyama, Y; Norikane, T; Takami, Y; Yamamoto, Y	1
A-Risheq, MZ; Alhouri, A; Juweid, ME; Mottaghy, FM; Mueller, M	1
Castro, AC; Mamede, M; Paulino, E; Ribeiro, TH; S, R	1
Abramson, JS; Advani, R; Ansell, S; Aurer, I; Bollard, C; Coiffier, B; de Vos, S; Dreyling, M; Elsayed, YA; Engert, A; Federico, M; Fisher, RI; Fortpied, C; Fowler, N; Gopal, A; Goy, A; Gribben, J; Hagenbeek, A; Hilden, P; Hutchings, M; Kaminski, MS; Kelly, K; Kloos, I; Kuruvilla, J; Leonard, JP; Little, RF; Meignan, M; Morschhauser, F; Pfreunschuh, M; Rademaker, J; Rule, S; Salles, G; Schoder, H; Schuster, SJ; Schwartz, LH; Sehn, LH; Seshan, VE; Seymour, JF; Smith, M; Takeshita, K; Thieblemont, C; Tobinai, K; Trneny, M; Valente, N; Van Oers, MHJ; Wilson, W; Witzig, TE; Younes, A; Zelenetz, AD; Zinzani, PL	1
Barrington, SF; Kluge, R	1
Kjaergaard, T; Petersen, KB	1
Bouabdallah, K; Hindié, E; Mesguich, C; Milpied, N	1
Byun, JM; Heo, DS; Jeon, YK; Kim, KH; Kim, M; Kim, TM; Lee, HY; Lee, JM; Lee, JO; Lee, JS; Paik, JH; Park, JH	1
Laffon, E; Marthan, R	1
Choi, W; D'Souza, WD; Kang, MK; Li, L; Lu, W; Tan, S	1
Bairey, O; Berger, T; Cohen, YC; Eshel, L; Raanani, P; Shpilberg, O; Stern, D	1
Barrington, SF; Johnson, PWM	1
Barrington, S; Hasenclever, D; Kluge, R; Kurch, L	1
Chakfé, N; Lejay, A	1
Giraudo, C; Jaeger, U; Karanikas, G; Mayerhoefer, ME; Raderer, M; Simonitsch-Klupp, I; Weber, M	1
Dickson, JC; Haryee, H; Miller, RF; Vora, N	1
Basher, RK; Das, A; Kalra, N; Malhotra, P; Mittal, BR; Prakash, G; Radhakrishnan, RK	1
Jiang, W; Wang, Q; Wang, Z; Xue, H; Zhang, X; Zhao, C	1
Chen, S; Fu, H; He, K; Ma, C; Wang, H; Wang, S	1
Fukunaga, H; Mutoh, T; Nakagawa, M; Shimomura, H; Taki, Y; Tatewaki, Y; Terao, C; Totsune, T; Yamamoto, S	1
Bechter, O; De Keyzer, F; De Paepe, KN; Dierickx, D; Janssens, A; Oyen, R; Vandecaveye, V; Verhoef, G; Wolter, P	1
Kuo, DJ; Paul, MR	1
Abadi-Korek, I; Bernstine, H; Domachevsky, L; Goldberg, N; Groshar, D; Nidam, M; Shpilberg, O	1
Fujii, H; Harata, N; Isogai, J; Nomoto, Y; Oota, S; Tanaka, H; Yoshida, K	1
Behringer, D; Bengel, FM; Berdel, WE; Bernhard, H; Bockisch, A; Brink, I; Brinkmann, M; Dührsen, U; Dürig, J; Franzius, C; Freesmeyer, M; Gaska, T; Geworski, L; Giagounidis, A; Griesshammer, M; Haberkorn, U; Hertel, A; Hertenstein, B; Hoelzer, D; Höffkes, HG; Holzinger, J; Hüttmann, A; Jöckel, KH; Klapper, W; Kofahl-Krause, D; Kotzerke, J; Krohn, T; Kroschinsky, F; Kurch, L; La Rosée, P; Maschmeyer, G; Matschke, J; Mesters, R; Müller, S; Ose, C; Pöppel, T; Prange-Krex, G; Raghavachar, A; Rekowski, J; Scherag, A; Schmitz, C; Thomssen, H; van Assema, DME; Weckesser, M; Wilop, S	1
Hussey, D; Maganti, M; Metser, U; Parvez, A; Tau, N	1
Enqvist, O; Lind, E; Polymeri, E; Sadik, M; Trägårdh, E; Ulén, J	1
Bashir, H; Hassan, A; Niazi, IK; Razi, M	1
Badr, S; Elahmadawy, MA; Kotb, M; Moustafa, H	1
Alfageme, F; Catalano, O; Koppula, V; Mandava, A; Wortsman, X	1
Abebe-Campino, G; Ben-Haim, S; Davidson, T; Hoffmann, C; Shrot, S; Toren, A	1
Chang, AH; Chen, D; Hu, Y; Huang, H; Wang, J; Wei, G; Wu, W; Wu, Z; Xiao, L; Yang, S; Zhang, Y; Zhao, K; Zhao, X	1
Lim, K; Maingard, J; Nambiar, M; Tai, R	1
Cartenì, G; Fusco, M; Pirozzi, A; Riccardi, F; Scagliarini, S	1
Anconina, R; Hod, N; Lantsberg, S; Levi, I; Levin, D; Nalbandyan, K	1
Galal, A; Wang, J	1
Anker, MS; Finke, D; Haberkorn, U; Heckmann, MB; Katus, HA; Lehmann, LH; Müller-Tidow, C; Totakhel, B	1
Choi, CW; Choi, TH; Hwang, JP; Kang, HJ; Kim, BI; Kim, KM; Lee, SS; Lim, I; Lim, SM; Park, JY; Yang, SH	1
Sioka, C	1
George, A; Hicks, RJ; Hofman, MS; Kashyap, R; Lade, S; Lau, E; Seymour, JF	1
Araf, S; Montoto, S	1
Takei, T; Uchiyama, M	1
Karanikas, G; Raderer, M; Toth, DF; Wadsak, W	1
Amthauer, H; Erdrich, AS; Furth, C; Grandt, R; Hauptmann, K; Hautzel, H; Hundsdoerfer, P; Kahraman, D; Kobe, C; Ruf, J; Schönberger, S; Steffen, IG; Stiebler, M	1
Guo, N; Li, JM; Li, XY; Zhu, HM	1
Chen, Y; Li, C; Li, F; Shen, Z; Tian, J; Wang, R; Xu, B; Yu, L; Zhu, H	1
Cui, Y; Dong, A; Gao, L; Wang, Y; Yang, J; Zuo, C	1
Dong, A; Wang, Y; Zhao, T; Zuo, C	1
Huang, G; Lu, J; Song, S; Wei, X; Zhu, Y	1
Eom, HS; Kang, SH; Kim, SK; Kim, TS; Kim, YI; Lee, H; Park, WS; Yun, T	1
Beppu, K; Himeji, D; Kawano, N; Kuriyama, T; Masuyama, H; Ono, N; Oshima, K; Oyama, M; Shimao, Y; Ueda, A; Ueda, Y; Yamaguchi, K; Yamashita, K; Yoshida, S	1
Cai, L; Fu, D; Fu, W; Gui, S; Li, J; Li, W; Lu, B; Tang, R; Yang, P; Zhang, H	1
Barker, C; Goenka, A; Gonen, M; Kowalski, A; Lim, R; Lovie, S; McCann, P; Schöder, H; Terezakis, SA; Turlakov, A; Yahalom, J	1
Canbaz Tosun, F; Cıraklı, A; Cıraklı, S; Dabak, N; Dağdemir, A; Elli, M	1
Hussey, D; Metser, U; Murphy, G	1
Macdonald, WB; McQuillan, AD; Turner, JH	1
Barrington, SF; Cavalli, F; Cheson, BD; Fisher, RI; Lister, TA; Schwartz, LH; Zucca, E	1
Heo, NY; Joo, YD; Kim, IH; Kim, JY; Kim, SH; Lee, SI; Park, JI; Park, SH; Shim, HK	1
Bachmann, KR; Foster, WC; Fox, MG; LeGallo, RD; Marti, JK	1
Bai, X; Chen, L; Gao, J; Hu, H; Nie, Y; Niu, X; Xu, H; Zhao, W	1
Bachanova, V; Burns, LJ; Cao, Q; Froelich, J; Kendi, AT; Lazaryan, A; Ustun, C	1
Bhojwani, D; Choi, JK; Davidoff, AM; Gold, R; Inaba, H; McCarville, MB; Metzger, ML; Sandlund, JT; Sawyer, J; Shulkin, BL	1
Luminari, S; Trotman, J	1
Marina, V; Milena, R; Slađana, P; Vera, A; Vesna, P	1
Antonelli, A; Grosso, M; Guidoccio, F	1
Cui, Y; Fan, Y; Fu, Z; Jiang, Q; Kang, L; Liao, X; Liu, M; Wang, R; Wang, Y; Zhang, J; Zhang, X	1
Adams, HJ; de Klerk, JM; Dubois, SV; Fijnheer, R; Kwee, TC; Nievelstein, RA	2
Carrió, I; Domenech, A; Escalera, S; Sampedro, F	1
Dominguez, ML; Garcia, L; Infante, JR; Moreno, M; Rayo, JI; Serrano, J	1
El-Galaly, TC; Hutchings, M	1
Adams, HJ; Kwee, TC	2
Bennani-Baiti, B; Bennani-Baiti, N; Flynt, L; Yadav, S	1
Dolak, W; Jaeger, U; Karanikas, G; Kiesewetter, B; Kletter, K; Knogler, T; Lukas, J; Mayerhoefer, ME; Müllauer, L; Porpaczy, E; Prosch, H; Raderer, M; Sillaber, C; Simonitsch-Klupp, I; Skrabs, C; Ubl, P; Weber, M	1
Ağlarcı, OS; Aral, CA; Hatipoğlu, F; Karaarslan, S; Sanal, MS; Taşlı, F; Yılmaz, HH	1
Carlos Herrera, J; Chen-Liang, TH; Contreras, J; Cozar, Mdel P; Fernandez-Gonzalez, M; Fernandez-Muñoz, H; Frutos, L; Igua, C; Jerez, A; Lancharro, A; Luis Navarro, J; Martin-Santos, T; Muiña, B; Orero, MT; Ortuño, FJ; Perez-Ceballos, E; Raya, JM; Remigia, MJ; Romera, M; Sanchez-Blanco, JJ; Sanchez-Vaño, R; Senent, L; Uña, J; Villegas, C	1
Dai, Y; Sowjanya, M; Xu, K; You, J	1
Agura, E; Ahn, KW; Akpek, G; Armand, P; Bachanova, V; Burns, LJ; Cairo, MS; Carreras, J; Cashen, AF; Cohen, JB; D'Souza, A; Freytes, CO; Gale, RP; Ganguly, S; Ghosh, N; Hamadani, M; Holmberg, LA; Inwards, DJ; Jaglowski, SM; Kanate, AS; Kharfan-Dabaja, MA; Laport, GG; Lazarus, HM; Malone, AK; Maloney, DG; Munker, R; Mussetti, A; Nishihori, T; Norkin, M; Prestidge, TD; Rowe, JM; Satwani, P; Siddiqi, T; Smith, SM; Stiff, PJ; Sureda, AM; William, BM; Wirk, B	1
Goldman, DA; Gönen, M; Lilienstein, J; Migliacci, J; Moskowitz, CH; Sauter, CS; Schöder, H; Ulaner, GA; Zelenetz, AD	1
Hwang, GY; Leung, GK; Li, LF; Lui, WM; Pu, JK; Taw, BB	1
Ahlström, H; Molin, D; Mosavi, F; Selling, J; Wassberg, C	1
Aide, N; Binns, D; Bourhis, D; Callahan, J; Desmonts, C; Hicks, RJ; Hofman, MS; Le Roux, PY; Quak, E; Robin, P; Salaun, PY	1
Bongioanni, F; Buschiazzo, A; Capitanio, S; De Astis, E; De Carli, F; Fiz, F; Marini, C; Miglino, M; Morbelli, S; Pomposelli, E; Sambuceti, G; Verardi, MT	1
English, JF; Sullivan, TJ	1
Tang, HJ	1
Asabella, AN; Brunese, L; Calabrese, A; de Fazio, V; De Tullio, G; Ferrari, C; Ficco, M; Guarini, A; Loseto, G; Maggialetti, N; Minoia, C; Rubini, G	1
Chen, G; Chen, S; Jiang, L; Li, Y; Shi, H	1
Degrieck, B; Goethals, I; Gykiere, P; Jans, L	1
Marcus, C; Nunna, P; Subramaniam, RM; Taghipour, M	1
De Renzo, A; Del Vecchio, S; Fonti, R; Nicolai, E; Salvatore, B	1
Ardeshna, K; Halsey, R; Kayani, I; Skoura, E; Wan, S	1
Li, P; Liu, Q; Lu, J; Luo, H; Song, S; Wang, C; Wu, S	1
Dolak, W; Giraudo, C; Karanikas, G; Kiesewetter, B; Mayerhoefer, ME; Raderer, M; Simonitsch-Klupp, I; Weber, M	1
Huang, J; Xie, P	1
Jones, S; Marcus, C; Sarangi, R; Subramaniam, RM; Taghipour, M; Trahan, TJ	1
Agrawal, A; Chandra, P; Purandare, N; Rangarajan, V; Shah, S	1
Abramson, JS; Arabasz, G; Atkinson, W; Barnes, J; Blake, MA; Catalano, O; Catana, C; Guimaraes, AR; Hochberg, E; McDermott, S; Muse, V; Rosen, BR; Shelly, M	1
Hubbard, J; Mohan, H; Moonim, M; Paschali, A	1
Afaq, A; Ardeshna, KM; Babikir, S; Ganeshan, B; Groves, AM; Kayani, I; Miles, KA; Shortman, R	1
Byun, BH; Choi, CW; Hwang, JP; Kim, BI; Lim, I; Lim, SM	1
Chi, KK; Kader, I; Leavers, B; Shashinder, S; Sundaresan, P; Wylie, B	1
Federico, M; Johnson, P; Trotman, J	1
Afaq, A; Akin, O; Ardeshna, K; Chen, SH; Fraioli, F; Groves, A; Kayani, I; Lambert, J; Linch, D; Miles, K; Punwani, S; Sidhu, H; Wan, S	1
Dai, D; Dong, YW; Fu, Q; Li, XF; Liu, JJ; Song, XY; Xu, WG; Zuo, C	1
Meignan, M	1
Chen, Y; Li, J; Qiu, L; Tu, G	1
Li, D; Qiu, H; Tian, T; Wang, L; Zhang, Q	1
Cousins, J; Currie, G; Czachowski, M; Muthukrishnan, A	1
Baetz, T; Dudebout, J; Hodgson, DC; Langer, DL; MacCrostie, P; Mak, V; Metser, U; Tau, N	1
Biesma, DH; Grutters, JC; Nieuwenhuizen, L; Verzijlbergen, FJ; Wiltink, E	1
Cheson, BD	1
Castellucci, P; Egesta, L; Fanti, S; Golemi, A; Grassetto, G; Nanni, C; Rubello, D; Stefoni, V; Tani, M; Tsamita, CS; Zinzani, PL	1
Ferguson, PJ; Khanna, G; Sato, TS	1
Israel, DA; Souza, FF	1
Chan, VC; Chaudhry, AA; Daw, HA; Farag, HL; Francis, S; Muslimani, AA; Spiro, TP; Taylor, HC	1
Escalón, MP; Han, HS; Hsiao, B; Lossos, IS; Serafini, A	1
Kostakoglu, L	2
Gunawardana, DH; Hicks, RJ; Ho Shon, I; Kirkwood, I; Ramshaw, JE; Robins, P; Scott, AM; Wong, J	1
Daimaru, O; Fukaya, N; Imai, T; Ito, S; Nagata, T; Uchida, H; Yamane, T; Yoshiya, K	1
Ahn, JS; Bom, HS; Cho, SH; Chung, IJ; Jeong, YY; Kim, HJ; Kim, YK; Lee, JJ; Min, JJ; Yang, DH	1
Ambrosini, V; Biassoni, L; Burnelli, R; Castellucci, P; Fanti, S; Lopci, E; Nanni, C; Rubello, D	1
Ambinder, RF; Blackford, AL; Bolaños-Meade, J; Borowitz, MJ; Fidyk, CA; Goodman, SN; Jones, RJ; Kasamon, YL; Rogers, KM; Swinnen, LJ; Wahl, RL; Ziessman, HA	1
Bou-Assaly, W; Broski, SM; Fig, LM; Gross, MD	1
Ahmadzadehfar, H; Biersack, HJ; Ezziddin, S; Hinterthaner, B; Näke, K; Sabet, A	1
Allen-Auerbach, M; Weber, WA	1
Fukunaga, H; Hatazawa, J; Higuchi, I; Kanakura, Y; Nakamura, H; Sugahara, H; Tatsumi, M	1
Khong, PL; Wong, CY	1
Escalon, MP; Kalkanis, D; Lossos, IS; Paes, F; Serafini, A; Stefanovic, A	1
Aide, N; Hicks, RJ; Irving, L	1
Goda, JS; Keller, H; Lockwood, G; Tsang, R; Vines, DC	1
Dufault, DL; Dunphy, CH; Ivanovic, M; Khandani, AH; Meteesatien, P; Shea, TC	1
Fan, W; Ma, LF	1
Feng, X; Guan, Y; Hua, F; Huang, Z; Zhao, J	1
Nishio, M; Ochi, H; Shibamoto, Y; Tamaki, T	1
de Haas, M; de Klerk, J; Fijnheer, R; Hoekstra, O; Kramer, M; Quarles van Ufford, H; Tieks, B; Wittebol, S	1
Conti, PS; de Kerviler, E; Delbeke, D; Gisselbrecht, C; Meignan, M; Stroobants, S	1
Betrouni, N; Cazaentre, T; Huglo, D; Morschhauser, F; Prangère, T; Steinling, M; Vermandel, M	1
Berthou, C; Boisramé, S; Ianotto, JC; Querellou, S; Tempescul, A; Valette, G	1
Ambrosini, V; Castellucci, P; Fanti, S; Franchi, R; Maffione, AM; Nanni, C; Rubello, D; Stefoni, V; Tani, M; Zinzani, P	1
Lam, WW; Osmany, S	1
Boellaard, R; Hoekstra, OS; Zijlstra, JM	1
Abdel-Dayem, HM; Hafez, M; Omar, W; Riad, R; Sidhom, I; Zaky, I; Zamzam, M	1
Kennedy, GA; Morris, K; Ravi Kumar, A; Restall, J	1
Fujita, H; Inayama, Y; Ishigatsubo, Y; Sakata, S; Takeuchi, K; Tanaka, M; Tateishi, U; Tomita, N; Watanabe, R	1
Hicks, RJ; Hofman, MS	1
Kalkanis, DG; Paes, FM; Serafini, AN; Sideras, PA	1
Qiao, W; Wang, C; Wang, T; Xing, Y; Zhao, J	2
Bilici, A; Canpolat, N; Gumus, M; Kefeli, U; Ozdemir, N; Salepci, T; Seker, M; Ustaalioglu, BB; Ustaalioglu, R; Yıldirim, E; Yilmaz, BE	1
Chassagne-Clément, C; Cimarelli, S; Heudel, PE; Janody, P; Lachenal, F; Ricard, F; Sebban, C	1
Ho, L; Negahban, A; Valenzuela, D; Wassef, H	1
Ahn, BC; Jeong, SY; Kang, S; Lee, HJ; Lee, J; Lee, SW; Seo, JH; Shin, KM; Song, BI	1
Bramanti, S; Castagna, L; Ciceri, F; Corradini, P; Crippa, F; Crocchiolo, R; Dodero, A; Englaro, E; Fallanca, F; Frungillo, N; Miceli, R; Milani, R; Patriarca, F	1
Goldschmidt, N; Klein, M; Or, O; Paltiel, O; Savitsky, B	1
Hong, TS; Navarro, OM; Punnett, A; Shammas, A	1
Hanaoka, K; Hosono, M; Ishii, K; Komeya, Y; Shimono, T; Sumita, M; Tatsumi, Y; Tsuchiya, N; Usami, K; Yamazoe, Y	1
Huo, L; Li, F; Luo, Y; Zhang, T; Zhao, Y; Zhu, Z	1
Beaven, A; Broadwater, G; Chao, N; Coleman, RE; Goggins, T; Horwitz, M; Palmer, J; Rizzieri, D; Sullivan, K	1
Buriánková, E; Dušek, L; Flodr, P; Indrák, K; Jarkovský, J; Koranda, P; Kubová, Z; Kučerová, L; Mysliveček, M; Palová, M; Papajík, T; Procházka, V; Raida, L; Sedová, Z	1
Gönen, M; Gonzales, AM; Hunt, MA; Kirov, AS; Kowalski, A; McCann, P; Reiner, A; Schmidtlein, CR; Schöder, H; Terezakis, SA; Yahalom, J	1
Argnani, L; Baccarani, M; Broccoli, A; Derenzini, E; Fanti, S; Gandolfi, L; Pellegrini, C; Quirini, F; Stefoni, V; Zinzani, PL	1
Hutchings, M	1
Amati, A; Arena, V; Bellò, M; Bisi, G; Douroukas, A; Passera, R; Pelosi, E; Penna, D	1
Feustel, PJ; Karam, M; Nazeer, T; Vera, CD	1
D'Souza, M; Guliani, S; Jain, J; Kumari, R; Mondal, A; Pandey, SK; Sharma, R; Tripathi, M	1
Juweid, ME	2
Chabbert, V; Julian, A; Payoux, P; Wagner, T; Ysebaert, L	1
Fijnheer, R; Kersten, MJ; Kwee, TC; Nievelstein, RA; van Leeuwen, MS; Vermoolen, MA	1
Hanaoka, K; Hosono, M; Ishii, K; Komeya, Y; Sumita, M; Tatsumi, Y; Tsuchiya, N; Usami, K; Yamazoe, Y	1
Alavi, A; Chamroonrat, W; Chen, W; Cheng, G; Torigian, DA; Zhuang, H	1
Buriankova, E; Dusek, L; Flodr, P; Hnatkova, M; Indrak, K; Jarkovsky, J; Koranda, P; Koza, V; Kubova, Z; Malan, A; Myslivecek, M; Papajik, T; Sedova, Z; Skopalova, M; Trneny, M	1
Blay, JY; Cimarelli, S; Ghesquières, H; Sebban, C; Sunyach, MP; Thiesse, P	1
Dammacco, F; Guariglia, R; Iodice, G; Musto, P; Reale, A; Ria, R; Vacca, A	1
Buriánková, E; Indrák, K; Kubová, Z; Kučerová, L; Melichar, B; Mikula, P; Mysliveček, M; Neoral, C; Papajík, T; Procházka, V; Raida, L; Sedová, Z; Starostka, D; Tichý, M	1
Chen, JH; Chen, YK; Kao, CH; Liang, JA; Tsui, CC; Yeh, CL	1
Liu, Y	1
Coya, J; del Campo, L; Gómez León, N; Hernández Maraver, D; Pinilla Fernández, I; Rodríguez-Vigil Junco, B	1
Asahi, S; Imamura, Y; Kimura, H; Kobayashi, M; Okazawa, H; Shimizu, K; Tsuchida, T; Tsuji, K; Tsujikawa, T	1
Bhattacharya, A; Das, R; Kashyap, R; Malhotra, P; Manohar, K; Mittal, BR; Varma, N; Varma, S	1
White, LR	1
Hatano, Y; Hayashi, Y; Hirose, Y; Hozumi, I; Inuzuka, T; Kasahara, S; Kato, J; Kimura, A; Koumura, A; Moriwaki, H; Nakamura, H; Sakurai, T; Takami, T; Tanaka, Y; Tsurumi, H; Yamada, M	1
Adib, S; Béron, A; Dewalle-Vignion, AS; Huglo, D; Lion, G; Petyt, G; Vermandel, M; Verscheure, L; Yeni, N	1
Guo, H; Iagaru, A; Mosci, C	1
Aversa, SM; Boscolo-Berto, R; Gardiman, M; Marino, D; Raduazzo, DI; Vezzaro, R	1
Bui, C; Fuller, S; Loh, H; Mansberg, R; Tow, J	1
Bakhshi, S; Dhawan, D; Kumar, R; Malhotra, A; Radhakrishnan, V; Sharma, P; Thulkar, S; Vishnubhatla, S	1
Il'in, NV; Khodzsibekova, MM; Kostenikov, NA; Mukhina, MS; Pozharisskiĭ, KM; Tiutin, LA	1
Chiewvit, S	1
Catalano, PJ; Halasz, LM; Jacene, HA; Lacasce, A; Mauch, PM; Ng, AK; Van den Abbeele, AD	1
Higashi, T; Nakamoto, Y; Nakatani, K; Saga, T; Togashi, K; Watanabe, K	1
Bongaerts, AH; Glaudemans, AW; van Rheenen, RW	1
Chang, CC; Chang, CS; Chen, YW; Cho, SF; Lin, CY; Tu, HP	1
Bhattacharya, A; Malhotra, P; Manohar, K; Mittal, BR; Varma, S	1
Bhattacharya, A; Malhotra, P; Manohar, K; Mittal, BR; Raja, S; Varma, S	1
Del Ciello, A; Di Franco, D; Treglia, G	1
Elstrom, RL	1
Cheng, G; Servaes, S; Zhuang, H	1
Bal, C; Kumar, R; Malhotra, A; Sharma, A; Sharma, P; Singh, H; Suman, SK	1
Akkas, BE; Vural, GU	1
Kim, CG; Kim, DW; Kim, WH	1
Hayabuchi, N; Hirose, Y; Ishibashi, M; Kaida, H; Miura, M; Miyazaki, K; Nakahara, K; Ogo, E; Ohshima, K; Okamura, T; Suefuji, H; Suzuki, G; Takasu, K; Uozumi, J; Watanabe, Y	1
Fan, Y; Fu, L; Li, H; Tian, J; Wang, H; Xu, B	1
Gianolli, L; Mapelli, P; Picchio, M; Vanoli, EG	1
Finke, J; Fritsch, K; Hader, C; Haug, V; Illerhaus, G; Kasenda, B; Meyer, PT; Mix, M; Schorb, E; Weber, WA	1
Bailly, C; Bodet-Milin, C; Dupas, B; Eugène, T; Gastinne, T; Kraeber-Bodéré, F; Le Gouill, S	1
Ceccarelli, S; Lacanfora, A; Schillaci, O; Simonetti, G; Travascio, L	1
Buell, U; Cremerius, U; Fabry, U; Nowak, B; Osieka, R; Reinartz, P; Schaefer, W; Wildberger, JE; Zimny, M	1
Beguin, YP; Jerusalem, GH	1
Coleman, M; Goldsmith, SJ; Kostakoglu, L; Kuji, I; Leonard, JP; Zoe, H	1
Lowe, VJ; Wiseman, GA	1
Lin, EC	1
Grahek, D; Kerrou, K; Landman-Parker, J; Leverger, G; McNamara, D; Montravers, F; Talbot, JN; Wioland, M; Younsi, N	1
Balzarini, J; de Groot, T; De Wolf-Peeters, C; Dupont, P; Mortelmans, L; Spaepen, K; Stroobants, S; Thomas, J; Vandenberghe, P; Verhoef, G	1
Chen, T; Hayashi, K; Kaneko, K; Koga, H; Kuwabara, Y; Masuda, K; Nakagawa, M; Nakamura, K; Sasaki, M	1
Bartsch, P; Belhocine, T; Green, A; Hustinx, R; Jerusalem, G; Rigo, P; Seidel, L; Steinmetz, N	1
Joyce, JM; Myers, DT; Petursson, SR; Pohland, ML	1
De Winter, F; Dierckx, RA; Kolindou, A; Lambert, B; Noens, L; Van De Wiele, C; Van Den Bossche, B	1
Alavi, A; Bagg, A; Baker, G; Downs, L; Elstrom, R; Guan, L; Kim, S; Mehrotra, A; Nakhoda, K; Pitsilos, S; Schuster, SJ; Vergilio, JA; Zhuang, H	1
Barrington, SF; Macdonald, EA; Mikhaeel, NG; O'Doherty, MJ; Schey, S	1
Daimaru, O; Imai, T; Itoh, S; Nagata, T; Ohishi, H; Shinai, T; Uchida, H; Yamane, T; Yoshiya, K	1
Beguin, Y; Fassotte, MF; Fillet, G; Foidart-Willems, J; Hustinx, R; Jérusalem, G; Silvestre, RM; Warland, V	1
Hoskin, PJ; O'Doherty, MJ	1
Mortelmans, L; Spaepen, K; Stroobants, S; Verhoef, G	1
Becherer, A; Jaeger, U; Kletter, K; Szabo, M	1
Bourguet, P	1
Eibl, M; Gallowitsch, HJ; Heinisch, M; Kresnik, E; Lind, P; Linkesch, W; Mikosch, P; Pipam, W; Unterweger, O; Zinke-Cerwenka, W	1
Blum, RH; Hicks, RJ; MacManus, M; Seymour, JF; Wirth, A	1
Beuthien-Baumann, B; Naumann, R	1
Balzarotti, M; Magagnoli, M; Santoro, A	1
Daimaru, O; Hashimoto, H; Ito, S; Kato, K; Nagata, T; Nishida, K; Uchida, H; Yamane, T; Yoshiya, K	1
Buchmann, I; Gfrörer, W; Glatting, G; Kotzerke, J; Leithäuser, F; Möller, P; Reske, SN; Schulte, M; Schultheiss, S; Vogg, AT	1
Byrne, DW; Delbeke, D; Greer, JP; Hallahan, DE; Lavely, WC; Morgan, DS; Price, RR	1
Joyce, JM; Kim, CE; Lichter, J; Patel, N	1
Alavi, A; Burns, J; Chiang, SB; Guan, L; Rebenstock, A; Zhuang, H	1
Lin, EC; Siegal, J	1
Constable, CJ; Fulham, MJ; Gradinscak, DJ; Mohamed, A	1
Döbert, N; Grünwald, F; Hamscho, N; Kovács, AF; Menzel, C; Podda, M; Wolter, M	1
Futatsubashi, M; Kanno, T; Kobayashi, M; Nakamura, F; Okada, H; Ouchi, Y; Torizuka, T; Yoshikawa, E	1
Comans, EF; Hoekstra, OS; Huijgens, PC; Jonkhoff, AR; Lammertsma, AA; Raijmakers, PG; Teule, GJ; v Tinteren, H; van der Hoeven, JJ; Zijlstra, JM	1
Antoch, G; Beyer, T; Bockisch, A; Debatin, JF; Freudenberg, LS; Görges, R; Jentzen, W; Müller, SP; Nowrousian, MR; Schütt, P	1
Carrasquillo, JA; Chen, CC; Little, RF; Nguyen, JD; Ryan, QC; Wilson, W	1
Chiusolo, P; Leone, G; Sica, S	1
Cui, RX; Zhou, Q	1
Borght, TV; Bosly, A; Krug, B; Mahy, N; Pirson, AS; Sonet, A	1
Bosi, A; Briganti, V; Castagnoli, A; Dini, C; Pagliai, F; Rigacci, L; Vaggelli, L	1
Cen, XN; Fan, Y; Fu, ZL; Wang, RF; Zhang, CL; Zhang, XM	1
Döbert, N; Grünwald, F; Hamscho, N; Kranert, WT; Menzel, C; Wördehoff, W	1
Goerres, GW; Hany, TF; Schaefer, NG; Seifert, B; Stumpe, KD; Taverna, C; von Schulthess, GK	1
Mackie, GC	1
Burton, C; Ell, P; Linch, D	1
Alavi, A; Kumar, R; Maillard, I; Schuster, SJ	1
Asaka, M; Nakada, K; Takei, T; Tamaki, N; Tsukamoto, E; Yamamoto, F; Zhao, S	1
Daimaru, O; Ito, S; Nagata, T; Uchida, H; Yamane, T; Yoshiya, K	1
Bouhnik, JP; Even-Sapir, E; Lerman, H; Levin, C; Lievshitz, G; Miller, E; Yuzefovich, B; Zak, O	1
De Barsy, C; Depas, G; Dresse, MF; Fassotte, MF; Foidart, J; Hoyoux, C; Hustinx, R; Jerusalem, G; Paquet, N; Rigo, P	1
Alinari, L; Baccarani, M; Battista, G; Boschi, S; Canini, R; Castellucci, P; Fanti, S; Farsad, M; Marengo, M; Monetti, N; Moretti, A; Nanni, C; Pettinato, C; Zinzani, P	1
Franzius, C; Heindel, W; Hermann, S; Hunold, A; Jürgens, H; Pixberg, M; Schober, O; Wormanns, D	1
Avivi, I; Bomanji, JB; Ell, PJ; Goldstone, AH; Hart, DP; Linch, DC; Mackinnon, S; Morris, EC; Peggs, KS; Thomson, KJ	1
Alavi, A; El-Haddad, G; Kumar, R; Mavi, A; Xiu, Y; Zhuang, H	1
Alavi, A; Alinari, L; Battista, G; Canini, R; Castellucci, P; Fanti, S; Farsad, M; Franchi, R; Monetti, N; Nanni, C; Pourdehnad, M; Rubello, D; Stefoni, V; Tani, M; Zinzani, P	1
Blumstein, NM; Cheson, BD; Graham, MM; Juweid, ME; Link, BK; Menda, Y; Mottaghy, FM; Reske, SN; Ritchie, JM; Rohren, EM; Stolpen, A; Vose, JM; Wiseman, GA; Wooldridge, JE	1
Erdi, YE; Gönen, M; Green, D; Larson, SM; Noy, A; Schöder, H; Weng, L; Yeung, HW	1
Altehoefer, C; Finke, J; Herkel, C; Moser, E; Reinhardt, MJ	1
Fields, PA; Hutchings, M; Mikhaeel, NG; O'Doherty, MJ; Timothy, AR	1
Coleman, M; Goldsmith, SJ; Kostakoglu, L; Leonard, JP	1
Apter, S; Ben-Bassat, I; Even-Sapir, E; Metser, U; Nagler, A; Naparstek, E; Perry, C; Polliack, A; Raanani, P; Shasha, Y	1
Avril, N; Jacobs, SA; Joyce, J; McCook, B; Torok, F; Vidnovic, N	1
Bibb, J; Hromas, R; Rabinowitz, I	1
Basu, S; Nair, N	1
Hany, TF; Strobel, K; Thuerl, CM	1
Faria, SC; Kazama, T; Macapinlac, HA; Mar, MV; Phongkitkarun, S; Podoloff, DA; Varavithya, V	1
Asakura, H; Mitani, M; Monden, T; Nishiyama, Y; Ohkawa, M; Takashima, H; Togami, T; Toyama, Y; Yamamoto, Y; Yokoe, K	1
Ak, I; Aydemir, B; Gülbaş, Z	1
Haioun, C; Itti, E; Meignan, M; Rahmouni, A; Reyes, F	1
Kanenishi, K; Komoto, D; Monden, T; Nishiyama, Y; Ohkawa, M; Ohno, M; Sasakawa, Y; Satoh, K; Toyama, Y; Yamamoto, Y	1
Alavi, A; Hernandez-Pampaloni, M; Takalkar, A; Yu, JQ; Zhuang, H	1
Guermazi, A; Juweid, ME	1
Arpaci, F; Arslan, N; Bulakbaşi, N; Kocaoğlu, M; Ozgüven, M; Oztürk, E	1
Altehoefer, C; Bucerius, J; Finke, J; Herkel, C; Joe, AY; Moser, E; Reinhardt, MJ	1
Ali, A; Cyriac, J; Karam, M; Nazeer, T; Novak, L; Nugent, F	1
Alavi, A; Andreadis, C; Berkowitz, A; Chong, EA; Downs, LH; Elstrom, R; Glatstein, E; Loren, AW; Luger, SM; Nasta, S; Porter, DL; Schuster, SJ; Siegel, DL; Stadtmauer, EA; Svoboda, J; Tsai, D	1
Delbeke, D; Frangoul, HA; Kuttesch, JF; Martin, W; Rhodes, MM; Shankar, S; Whitlock, JA	1
Mikhaeel, NG	1
Alavi, A; Newberg, A; Srinivas, SM; Sydow, BD	1
Al-Nahhas, A; Alavi, A; Ambrosini, V; Castellucci, P; Fanti, S; Farsad, M; Nanni, C; Rubello, D; Tehranipour, N; Zinzani, P	1
Gomes, M; Kotb, R; McFadden, N; Sawan, B; Schmutz, G; Turcotte, E	1
Bar Shalom, R; Ben Arush, MW; Haimi, M; Israel, O; Militianu, D; Postovsky, S; Zaidman, I	1
Bodet-Milin, C; Carlier, T; Chatal, JF; Couturier, O; Harousseau, JL; Oudoux, A; Querellou, S; Valette, F	1
Jhanwar, YS; Straus, DJ	1
de Bruin, HG; Rosso, SM; van den Bent, MJ; Wu, KL	1
Allen, C; Grimes, D; Sullivan, TJ; Valenzuela, AA; Wong, D	1
Pruim, J; Schot, BW; Sluiter, WJ; Vaalburg, W; van Imhoff, GW; Vellenga, E; Zijlstra, JM	1
Coya, J; Gómez-León, N; Hernández-Maraver, D; Madero, R; Martín-Curto, L; Pinilla, I; Rodríguez-Vigil, B	1
Coya, J; Gomez-Leon, N; Hernandez-Maraver, D; Hernandez-Navarro, F; Madero, R; Martin-Curto, LM; Pinilla, I; Rodriguez-Vigil, B	1
Alinari, L; Ambrosini, V; Berkowitz, A; Castellucci, P; Elstrom, R; Fanti, S; Farsad, M; Franchi, R; Nanni, C; Stefoni, V; Tani, M; Zinzani, PL	1
Ben-Yehuda, D; Cohen, T; Freund, HR; Klein, M; Krausz, Y; Nissan, A	1
Canessa G, J; González E, P; Humeres A, P; Jofré M, MJ; Massardo V, T; Sierralta G, P	1
Rademaker, J	1
Cheson, BD; Coiffier, B; Connors, JM; Diehl, V; Dreyling, M; Federico, M; Fisher, RI; Gascoyne, RD; Hagenbeek, A; Hoppe, RT; Horning, SJ; Juweid, ME; Lister, TA; Pfistner, B; Rosen, ST; Specht, L; Stroobants, S; Tobinai, K; Vose, JM; Zucca, E	1
Armitage, J; Barker, A; Carucci, D; Cheson, B; Christian, M; Daube-Witherspoon, M; deGennaro, LJ; Dodd, L; Farrell, AT; Gastonis, C; Graham, M; Higley, HR; Horning, SJ; Juweid, M; Kelloff, GJ; Korn, E; Kostakoglu, L; Larson, SM; Lee, DB; Mills, GQ; O'connor, OA; Pazdur, R; Sargent, DJ; Schilsky, R; Shankar, LK; Siegel, BA; Sigal, E; Sigman, CC; Sullivan, DM; Timko, D; Wahl, RL; Wang, SJ; Weber, W; Wilson, W; Woodcock, J; Zelenetz, AD	1
Alavi, A; Bing, Z; Chamroonrat, W; Houseni, M; Yang, H; Zhuang, H	1
Bui, C; Frey, KA; Hutchinson, RJ; Mody, RJ; Shulkin, BL	1
Bonardel, G; Brisse, H; Edeline, V; Foehrenbach, H; Gaillard, JF; Maszelin, P; Michon, J; Neuenschwander, S; Pacquement, H	1
Bairey, O; Shpilberg, O	1
Inoue, Y; Iwasaki, H; Nakatsuka, S; Soma, T; Tamaki, H; Yamagami, T	1
Halkar, RK; Kost, CB; Reilly, TB; Schuster, DM; Starsiak, MD	1
Endo, K; Handa, H; Hasegawa, M; Kojima, M; Matsushima, T; Murakami, H; Oriuchi, N; Saitoh, T; Tsukamoto, N; Yokohama, A	1
Specht, L	1
Blondet, C; Cimarelli, S; Constantinesco, A; Fohrer, C; Herbrecht, R; Imperiale, A	1
Aupérin, A; Bonniaud, G; Bosq, J; Couanet, D; Edeline, V; Fermé, C; Leboulleux, S; Lumbroso, J; Masson, F; Pigneur, F; Ribrag, V; Schlumberger, M; Vanel, D	1
Fischer, K; Hany, TF; Jung, HH; Poryazova, R; Strobel, K	1
Brepoels, L; De Wever, W; De Wolf-Peeters, C; Mortelmans, L; Spaepen, K; Stroobants, S; Thomas, J; Uyttebroeck, A; Vandenberghe, P; Verhoef, G	1
Even-Sapir, E; Herishanu, Y; Lerman, H; Lievshitz, G; Metser, U; Perry, C	1
Hicks, RJ; MacManus, MP; Seymour, JF	1
Karantanis, D; Lowe, VJ; Mullan, BP; Nathan, MA; O'eill, BP; Peller, PJ; Subramaniam, RM; Wiseman, GA; Witte, RJ	1
Weber, WA	1
Bar-Shalom, R; Eldad, DJ; Fischer, D; Ghersin, E; Halachmi, S; Keidar, Z	1
Mortelmans, L; Moulin-Romsee, G	1
Altamirano, J; Calvo, PS; Chalapud Revelo, JR; de la Garza Salazar, J; Esparza, JR; Estrada, G; Vera, SR	1
Hotta, T; Nagai, H; Nihashi, T; Terasawa, T	1
Hampson, FA; Shaw, AS	1
Li, G; Zhang, Y; Zhuang, H	1
Mortelmans, L; Moulin-Romsee, G; Spaepen, K; Stroobants, S	1
Bisi, G; Chiappella, A; Deandreis, D; Pelosi, E; Penna, D; Skanjeti, A; Vitolo, U	1
Bodet-Milin, C; Campion, L; Dupas, B; Gastinne, T; Goldenberg, DM; Harousseau, JL; Huglo, D; Kraeber-Bodéré, F; Le Gouill, S; Morschhauser, F; Wegener, WA	1
Bartenstein, P; Becker, C; Bröckel, N; Hacker, M; Hundt, W; la Fougère, C; Morhard, D; Pfluger, T; Schneider, V; Tiling, R	1
Chua, SC; Green, DJ; Rozalli, FI	1
Kasamon, YL; Wahl, RL	1
Bodet-Milin, C; Campion, L; Dupas, B; Kraeber-Bodéré, F; Le Gouill, S; Moreau, P	1
Johnston, PB; Micallef, IN; Wiseman, GA	1
Andemariam, B; Chadburn, A; Coleman, M; Elstrom, RL; Fahey, TJ; Furman, RR; Goldsmith, SJ; Leonard, JP; Martin, P; Niesvizky, R; Philips, SM; Rutherford, SC	1
Assanelli, A; Bernardi, M; Bordignon, C; Caligaris-Cappio, F; Canevari, C; Ciceri, F; Clerici, D; Crocchiolo, R; Fazio, F; Ferreri, A; Gianolli, L; Landoni, C; Lunghi, F; Peccatori, J; Servida, P; Stanghellini, ML; Tassara, M	1
Bisi, G; Chiappella, A; Deandreis, D; Gallo, E; Limerutti, G; Mancini, M; Pelosi, E; Penna, D; Pregno, P; Vitolo, U	1
Bishton, MJ; Hicks, RJ; Prince, MH; Seymour, JF; Westerman, DA; Wolf, M	1
Ahlström, H; Glimelius, B; Rehn, S; Rodriguez, M; Sundström, C	1
Bergman, J; Haaparanta, M; Joensuu, H; Klemi, PJ; Lapela, M; Leskinen, S; Lindholm, P; Minn, HR; Ruotsalainen, U; Söderström, KO; Solin, O	1
Dimitrakopoulou-Strauss, A; Goldschmidt, H; Lorenz, WJ; Maier-Borst, W; Strauss, LG; van Kaick, G	1
Arimizu, N; Imaseki, K; Itami, J; Okada, J; Oonishi, H; Uno, K; Yoshikawa, K	2
Alpert, NM; Fischman, AJ; Goldberg, MA; Lee, MJ; Mueller, PR; Thrall, JH	1
Golding, R; Hoekstra, OS; Ossenkoppele, GJ; Teule, GJ; van Lingen, A	1
Bares, R; Büll, U; Dempke, W; Galonska, P; Handt, S; Osieka, R	1
Golding, R; Hoekstra, OS; Huijgens, PC; Ossenkoppele, GJ; Teule, GJ; van Lingen, A; Visser, GW	1
de Wit, M; Durig, J; Fiedler, W; Hossfeld, DK; Steffen, M	1
Beaney, RP; Chevretton, EB; Walsh, RM; Wong, WL	1
Dahlbom, M; Glaspy, J; Hawkin, RA; Hoh, CK; Kunkel, L; Lee, SJ; Maddahi, J; Phelps, ME; Rosen, P	1
Coleman, RE; Lee, VS; Martinez, S	1
Dimitrakopoulou-Strauss, A; Goldschmidt, H; Hegenbart, U; Irngartinger, G; Oberdorfer, F; Strauss, LG; van Kaick, G	1
Bangerter, M; Diederichs, CG; Guhlmann, A; Herrmann, F; Kolokythas, O; Kotzerke, J; Merkle, E; Moog, F; Reske, SN	1
Beyer, W; Bumann, D; Clausen, M; de Wit, M; Herbst, K; Hossfeld, DK	1
Ahlström, H; Glimelius, B; Hagberg, H; Rehn, S; Rodriguez, M; Sundín, A; Sundström, C	1
Büll, U; Cremerius, U; Fabry, U; Günther, R; Hellwig, D; Neuerburg, J; Osieka, R; Thill, R; Wagenknecht, G	1
Bangerter, M; Diederichs, CG; Frickhofen, N; Guhlmann, A; Merkle, E; Moog, F; Reske, SN	1
Bangerter, M; Frickhofen, N; Guhlmann, A; Kotzerke, J; Moog, F; Reske, SN	1
Bangerter, M; Ellenrieder, V; Griesshammer, M; Hafner, M; Heimpel, H; Merkle, E; Moog, F; Reske, SN	1
Alavi, A; Alavi, JB; Bénard, F	1
Enne, W; Fuchs, C; Garbrecht, M; Hanauske, AR; Herz, M; Nerl, C; Römer, W; Schwaiger, M; Thödtmann, R; Weber, W; Ziegler, S	1
Beese, M; Beyer, W; Bücheler, E; Bumann, D; Clausen, M; de Wit, M; Lübeck, M	1
Rodriguez, M	1
Fuchs, C; Garbrecht, M; Römer, W; Schwaiger, M	1
Buck, A; Glanzmann, C; Steinert, HC; Stumpe, KD; Urbinelli, M; von Schulthess, GK	1
Bakheet, SM; Ezzat, A; Powe, J; Rostom, A	1
Buell, U; Cremerius, U; Fabry, U; Neuerburg, J; Osieka, R; Zimny, M	1
Frickhofen, N; Guhlmann, A; Kotzerke, J; Moog, F; Reske, SN	1
Fassotte, MF; Fillet, G; Jerusalem, G; Najjar, F; Paulus, P; Rigo, P; Warland, V	1
Büll, U; Cremerius, U; Fabry, U; Kröll, U; Neuerburg, J; Osieka, R; Zimny, M	1
Beguin, Y; Fassotte, MF; Fillet, G; Jerusalem, G; Najjar, F; Paulus, P; Rigo, P	2
Collins, BT; Dunphy, FR; Lowe, VJ	1
Bergman, J; Haaparanta, M; Knuuti, J; Laine, H; Minn, H; Nuutinen, J; Ruotasalainen, U	1
Bohuslavizki, KH; Buchert, R; de Wit, M; Igel, B; Lorenzen, J	1
Hain, SF; Mikhaeel, NG; O'Doherty, MJ; Timothy, AR	1
Buchmann, I; Moog, F; Reske, SN; Schirrmeister, H	1
Kaminski, MS; Kison, PV; Rommelfanger, SG; Torizuka, T; Wahl, RL; Zasadny, KR	1
Gibson, P; Hoskin, P; Lowe, J; McMillan, A; Shah, N; wong, WL	1
Kim, HC; Kim, HS; Lee, J; Park, CH	1
Hwang, K; Kim, H; Kim, HC; Kim, S; Pai, M; Park, CH; Yoon, S	1
Fridrik, M; Hatzl-Griesenhofer, M; Huber, H; Maschek, W; Pichler, R; Wahl, G; Wimmer, G	1
Avril, N; Schwaiger, M; Stahl, A; Weber, WA	1
Balzarini, J; Bormans, G; De Wolf-Peeters, C; Dupont, P; Mortelmans, L; Spaepen, K; Stroobants, S; Thomas, J; Van Steenweghen, S; Vandenberghe, P; Vanuytsel, L; Verhoef, G	1
Kuwert, T	1
Bakheet, R; Bakheet, SM; Durakovic, A; Ezzat, A; Hussain, S; Tulbah, A	1
Hwang, KH; Kim, MK; Kim, S; Park, CH; Yoon, SN	1
Kanakura, Y; Kitayama, H; Nakamura, H; Nishimura, T; Sugahara, H; Tatsumi, M; Tokita, N	1
Segall, GM	1
Hain, S; Maisey, MN; Mikhaeel, NG; O'Doherty, MJ; Timothy, AR	1
Alavi, A; Liu, Y; Pourdehnad, M; Sinha, P; Yamamoto, AJ; Zhuang, H	1
Bares, R; Büll, U; Cremerius, U; Fabry, U; Neuerburg, J; Osieka, R; Zimny, M	1
Bar-Shalom, R; Goldsmith, SJ; Mor, M; Yefremov, N	1
Ariannejad, M; Czernin, J; Meta, J; Phelps, ME; Rao, J; Sayre, J; Schöder, H; Valk, PE; Yap, C	1
Beguin, Y; Fassotte, MF; Fillet, G; Hustinx, R; Jerusalem, G; Najjar, F; Rigo, P	1
Domagk, D; Domschke, W; Franzius, CH; Sciuk, J; Seidel, M; Ullerich, H	1
Hosono, T; Kawamura, T; Kurabayashi, M; Maeno, T; Maeno, Y; Nagai, R; Sando, Y; Sato, M; Suga, T; Tajima, S	1
Fillet, G; Hustinx, R; Jerusalem, G; Najjar, F; Rigo, P	1
Alavi, A; Matthies, A; Schuster, SJ	1
Buchmann, I; Reske, SN	1
Alavi, A; Ghesani, N; Hongming, Z; Mozley, D; Schusper, S; Shih, WJ	1
Mortelmans, L; Spaepen, K	1
Becherer, A; Dudczak, R; Greinix, HT; Jaeger, U; Kalhs, P; Karanikas, G; Kletter, K; Mitterbauer, M; Pötzi, C; Raderer, M	1
Beuthien-Baumann, B; Bredow, J; Ehninger, G; Franke, WG; Kittner, T; Kropp, J; Naumann, R; Vaic, A	1
Fisher, R; Hicks, RJ; Januszewicz, H; MacManus, MP; Prince, M; Ryan, G; Seymour, JF; Ware, R; Wirth, A; Wolf, M	1
Kaplan, LD	1
Hoskin, PJ	1
Coleman, M; Goldsmith, SJ; Kostakoglu, L; Kuji, I; Leonard, JP; Vallabhajosula, S	1
Higuchi, T	1
Haberkorn, U; Reisser, C; Strauss, LG	1
Bischoff, H; Knopp, MV; Oberdorfer, F; van Kaick, G	1
Daemen, BJ; Elsinga, PH; Konings, AW; Lemstra, W; Paans, AM; Vaalburg, W	1
Arimizu, N; Imazeki, K; Itami, J; Kuyama, J; Maruno, H; Minoshima, S; Okada, J; Uno, K; Yoshikawa, K	1
Joensuu, H; Leskinen-Kallio, S; Någren, K; Ruotsalainen, U; Teräs, M	1
Paul, R	1

Reviews

51 review(s) available for fluorodeoxyglucose f18 and Lymphoma, Non-Hodgkin

Article	Year
Current Role of Functional Imaging in the Management of Lymphoma. Current oncology reports, 2021, 11-04, Volume: 23, Issue:12 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Practice Guidelines as Topic	2021
Whole body FDG-PET/CT for the assessment of bone marrow infiltration in patients with newly diagnosed lymphoma. Medicina clinica, 2020, 01-24, Volume: 154, Issue:2 Topics: Adult; Aged; Biopsy; Bone Marrow; Bone Marrow Examination; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Ilium; Liver; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Whole Body Imaging; Young Adult	2020
Update on Hodgkin lymphoma from a radiologist's perspective. Clinical imaging, 2020, Volume: 65 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Radiologists; Radiopharmaceuticals; Tomography, X-Ray Computed	2020
Diagnostic Yield of Extensive Systemic Staging Including Whole-body 18F-fluoro-deoxy-glucose Positron Emission Tomography With or Without Computed Tomography in Patients With Primary Central Nervous System Lymphoma: Systematic Review and Meta-analysis. Clinical lymphoma, myeloma & leukemia, 2020, Volume: 20, Issue:11 Topics: Central Nervous System Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed	2020
Diagnostic Performance of Pretreatment 18F-Fluorodeoxyglucose Positron Emission Tomography With or Without Computed Tomography in Patients With Primary Central Nervous System Lymphoma: Updated Systematic Review and Diagnostic Test Accuracy Meta-analyses. Clinical lymphoma, myeloma & leukemia, 2021, Volume: 21, Issue:8 Topics: Central Nervous System Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neuroimaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity	2021
Positron emission tomography/computed tomography in the management of Hodgkin and B-cell non-Hodgkin lymphoma: An update. Cancer, 2021, 10-15, Volume: 127, Issue:20 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Tumor Burden	2021
International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017). Annals of oncology : official journal of the European Society for Medical Oncology, 2017, Jul-01, Volume: 28, Issue:7 Topics: Antineoplastic Agents; Consensus; Contrast Media; Disease Progression; Disease-Free Survival; Endpoint Determination; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Response Evaluation Criteria in Solid Tumors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden	2017
FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas. European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:Suppl 1 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Treatment Outcome	2017
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017, Volume: 58, Issue:10 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron Emission Tomography Computed Tomography; Precision Medicine	2017
The utility of FDG PET in diagnosis and follow-up of lymphoma in childhood. European journal of pediatrics, 2013, Volume: 172, Issue:6 Topics: Chemoradiotherapy; Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals	2013
The predictive value of interim and final [18F] fluorodeoxyglucose positron emission tomography after rituximab-chemotherapy in the treatment of non-Hodgkin's lymphoma: a meta-analysis. BioMed research international, 2013, Volume: 2013 Topics: Antibodies, Monoclonal, Murine-Derived; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Proportional Hazards Models; Publication Bias; Rituximab	2013
Impact of (18)F-FDG PET/CT on the staging and management of follicular lymphoma. The British journal of radiology, 2014, Volume: 87, Issue:1042 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed	2014
Imaging of non-Hodgkin lymphomas: diagnosis and response-adapted strategies. Cancer treatment and research, 2015, Volume: 165 Topics: Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed; Treatment Outcome	2015
Non-Hodgkin's Lymphoma of Multiple Skeletal Muscles Involvement Seen on FDG PET/CT Scans. Medicine, 2015, Volume: 94, Issue:18 Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Muscle Neoplasms; Muscle, Skeletal; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
The role of fluorine-18 fluorodeoxyglucose PET in prognosis evaluation for stem cell transplantation of lymphoma: a systematic review and meta-analysis. Nuclear medicine communications, 2016, Volume: 37, Issue:4 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Prognosis; Stem Cell Transplantation	2016
The role of 18F-FDG PET and PET/CT in the evaluation of primary cutaneous lymphoma. Nuclear medicine communications, 2017, Volume: 38, Issue:2 Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Skin Neoplasms	2017
Measuring response with FDG-PET: methodological aspects. The oncologist, 2009, Volume: 14, Issue:4 Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Uterine Cervical Neoplasms	2009
PET imaging in lymphoma. Expert review of hematology, 2009, Volume: 2, Issue:3 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals	2009
FDG-PET/CT in lymphoma. Methods in molecular biology (Clifton, N.J.), 2011, Volume: 727 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed	2011
Magnetic resonance imaging of malignant lymphoma. Expert review of hematology, 2011, Volume: 4, Issue:2 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging	2011
F-18 FDG PET for evaluation of bone marrow involvement in non-Hodgkin lymphoma: a meta-analysis. Clinical nuclear medicine, 2011, Volume: 36, Issue:7 Topics: Bone Marrow; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Quality Assurance, Health Care; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed	2011
Demonstrations of AIDS-associated malignancies and infections at FDG PET-CT. Annals of nuclear medicine, 2011, Volume: 25, Issue:8 Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Female; Fluorodeoxyglucose F18; HIV Infections; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms; Opportunistic Infections; Positron-Emission Tomography; Sarcoma, Kaposi; Tomography, X-Ray Computed; Tuberculosis	2011
Positron emission tomography in non-Hodgkin's lymphoma (NHL): relationship between tracer uptake and pathological findings, including preliminary experience in the staging of low-grade NHL. Clinical lymphoma, 2002, Volume: 3, Issue:1 Topics: Carbon Radioisotopes; Cell Division; Disease Progression; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Methionine; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed	2002
[End of treatment evaluation in patients with aggressive non-Hodgkin's lymphoma]. Revue medicale de Liege, 2002, Volume: 57, Issue:12 Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma, Non-Hodgkin; Neoplasm, Residual; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome	2002
Positron emission tomography in the management of lymphomas: a summary. European journal of nuclear medicine and molecular imaging, 2003, Volume: 30 Suppl 1 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Radiopharmaceuticals; Tomography, Emission-Computed	2003
Positron emission tomography with [(18)F]FDG for therapy response monitoring in lymphoma patients. European journal of nuclear medicine and molecular imaging, 2003, Volume: 30 Suppl 1 Topics: Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Predictive Value of Tests; Prognosis; Radioimmunotherapy; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed	2003
Prognostic value of FDG-PET in malignant lymphoma. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 2003, Volume: 47, Issue:1 Topics: Citrates; Fluorodeoxyglucose F18; Gallium; Hodgkin Disease; Indium Radioisotopes; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Thallium; Tomography, Emission-Computed; Treatment Outcome	2003
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in the treatment of Hodgkin's disease and malignant non-Hodgkin's lymphoma]. Bulletin du cancer, 2003, Volume: 90 Spec No Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome	2003
Fortuitous detection of papillary carcinoma of the thyroid with F-18 FDG positron emission tomography in a patient with non-Hodgkin lymphoma. Clinical nuclear medicine, 2003, Volume: 28, Issue:9 Topics: Adult; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed	2003
The role of PET imaging in lymphoma. British journal of haematology, 2004, Volume: 126, Issue:6 Topics: Adult; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Tomography, Emission-Computed; Treatment Outcome	2004
Utility of fluorodeoxyglucose-PET imaging in the management of patients with Hodgkin's and non-Hodgkin's lymphomas. Radiologic clinics of North America, 2004, Volume: 42, Issue:6 Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Patient Care Planning; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Whole-Body Counting	2004
FDG-PET imaging in primary bilateral adrenal lymphoma: a case report and review of the literature. Clinical nuclear medicine, 2005, Volume: 30, Issue:4 Topics: Adrenal Gland Neoplasms; Aged; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Radiopharmaceuticals; Rare Diseases	2005
The role of FDG-PET imaging in the management of lymphoma. Clinical advances in hematology & oncology : H&O, 2004, Volume: 2, Issue:2 Topics: Bone Marrow; Clinical Trials as Topic; Disease Management; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Imaging, Three-Dimensional; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome	2004
How much intravenous contrast is needed in FDG-PET/CT? Nuklearmedizin. Nuclear medicine, 2005, Volume: 44 Suppl 1 Topics: Contrast Media; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Ovarian Neoplasms; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2005
Value of [18F]fluorodeoxyglucose-positron emission tomography in managing patients with aggressive non-Hodgkin's lymphoma. Clinical lymphoma & myeloma, 2006, Volume: 6, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiography; Radiopharmaceuticals	2006
Use of FDG-PET to monitor response to chemotherapy and radiotherapy in patients with lymphomas. European journal of nuclear medicine and molecular imaging, 2006, Volume: 33 Suppl 1 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Treatment Outcome	2006
The role of PET in lymphoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006, Volume: 47, Issue:8 Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Image Processing, Computer-Assisted; Lymphoma, Non-Hodgkin; Medical Oncology; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome	2006
[Role of 18Fluorine-deoxyglucose (FDG) positron emission tomography in the management of lymphomas]. Revista medica de Chile, 2006, Volume: 134, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity	2006
Is bone marrow biopsy obligatory in all patients with non-Hodgkin's lymphoma? Acta haematologica, 2007, Volume: 118, Issue:1 Topics: Biopsy, Needle; Bone Marrow; Bone Marrow Examination; Decision Making; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Lymphoma, Non-Hodgkin; Male; Patient Selection; Positron-Emission Tomography; Prognosis; Risk Assessment; Sensitivity and Specificity; Unnecessary Procedures	2007
2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas. Seminars in radiation oncology, 2007, Volume: 17, Issue:3 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neoadjuvant Therapy; Neoplasm Staging; Neoplasm, Residual; Patient Care Planning; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Conformal; Tomography, X-Ray Computed; Treatment Outcome	2007
Fluorine-18 fluorodeoxyglucose PET/CT patterns of extranodal involvement in patients with Non-Hodgkin lymphoma and Hodgkin's disease. Radiologic clinics of North America, 2007, Volume: 45, Issue:4 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed	2007
Overview of early response assessment in lymphoma with FDG-PET. Cancer imaging : the official publication of the International Cancer Imaging Society, 2007, Volume: 7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Disease Management; Disease Progression; Disease-Free Survival; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Middle Aged; Outcome Assessment, Health Care; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals	2007
18F-FDG PET as a routine test for posttherapy assessment of Hodgkin's disease and aggressive non-Hodgkin's lymphoma: where is the evidence? Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008, Volume: 49, Issue:1 Topics: Evidence-Based Medicine; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals	2008
18F-FDG PET for posttherapy assessment of Hodgkin's disease and aggressive Non-Hodgkin's lymphoma: a systematic review. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008, Volume: 49, Issue:1 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity	2008
Response assessment in lymphoma. Clinical radiology, 2008, Volume: 63, Issue:2 Topics: Central Nervous System Neoplasms; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Tomography, X-Ray Computed	2008
FDG PET and risk-adapted therapy in Hodgkin's and non-Hodgkin's lymphoma. Current opinion in oncology, 2008, Volume: 20, Issue:2 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors; Treatment Outcome	2008
Positron emission tomography using F-18 fluorodeoxyglucose pre- and post-autologous stem cell transplant in non-Hodgkin's lymphoma. Bone marrow transplantation, 2008, Volume: 41, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Stem Cell Transplantation; Transplantation, Autologous	2008
The value of Ga-67 scintigraphy and F-18 fluorodeoxyglucose positron emission tomography in staging and monitoring the response of lymphoma to treatment. Seminars in nuclear medicine, 2001, Volume: 31, Issue:3 Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Radiopharmaceuticals; Tomography, Emission-Computed	2001
Novel imaging techniques in NHL: clinical results with PET imaging. Annals of hematology, 2001, Volume: 80 Suppl 3 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Neoplasm, Residual; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed	2001
Evaluation of treatment response in patients with lymphoma using [18F]FDG-PET: differences between non-Hodgkin's lymphoma and Hodgkin's disease. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 2001, Volume: 45, Issue:3 Topics: Fluorine; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome	2001
[Positron emission tomography of the thorax. The current clinical status]. Der Radiologe, 1992, Volume: 32, Issue:6 Topics: Carcinoma, Bronchogenic; Deoxyglucose; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Tomography, Emission-Computed	1992

Trials

34 trial(s) available for fluorodeoxyglucose f18 and Lymphoma, Non-Hodgkin

Article	Year
Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification: a post-hoc analysis of the PETAL trial. Leukemia, 2022, Volume: 36, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Prednisone; Rituximab; Vincristine	2022
Development of a radiomic-clinical nomogram for prediction of survival in patients with diffuse large B-cell lymphoma treated with chimeric antigen receptor T cells. Journal of cancer research and clinical oncology, 2023, Volume: 149, Issue:13 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Nomograms; Positron Emission Tomography Computed Tomography; Receptors, Chimeric Antigen; Retrospective Studies; T-Lymphocytes	2023
FDG PET/CT parameters and correlations with tumor-absorbed doses in a phase 1 trial of European journal of nuclear medicine and molecular imaging, 2021, Volume: 48, Issue:6 Topics: Antibodies, Monoclonal; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Positron Emission Tomography Computed Tomography	2021
Post-therapy lesions in patients with non-Hodgkin's lymphoma characterized by 18F-FDG PET/CT-guided biopsy using automated robotic biopsy arm. Nuclear medicine communications, 2018, Volume: 39, Issue:1 Topics: Adult; Automation; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Robotic Surgical Procedures; Young Adult	2018
Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, 07-10, Volume: 36, Issue:20 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prednisone; Prognosis; Rituximab; Treatment Outcome; Vincristine	2018
Phase II study of first-line (131)I-rituximab radioimmunotherapy in follicular non-Hodgkin lymphoma and prognostic (18)F-fluorodeoxyglucose positron emission tomography. Leukemia & lymphoma, 2015, Volume: 56, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Radioimmunotherapy; Rituximab; Tomography, X-Ray Computed; Treatment Outcome	2015
Impact of Pretransplantation (18)F-fluorodeoxy Glucose-Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2015, Volume: 21, Issue:9 Topics: Adolescent; Adult; Aged; Allografts; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiography; Survival Rate	2015
The combined evaluation of interim contrast-enhanced computerized tomography (CT) and FDG-PET/CT predicts the clinical outcomes and may impact on the therapeutic plans in patients with aggressive non-Hodgkin's lymphoma. Annals of hematology, 2009, Volume: 88, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Metabolism; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Prognosis; Remission Induction; Survival Analysis; T-Lymphocytes; Tomography, X-Ray Computed; Treatment Outcome; Young Adult	2009
Phase II study of risk-adapted therapy of newly diagnosed, aggressive non-Hodgkin lymphoma based on midtreatment FDG-PET scanning. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2009, Volume: 15, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Platinum Compounds; Positron-Emission Tomography; Prognosis; Risk Assessment; Salvage Therapy; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Young Adult	2009
Predictive value of (18)F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation. Hematology (Amsterdam, Netherlands), 2010, Volume: 15, Issue:1 Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Predictive Value of Tests; Prednisolone; Prednisone; Proportional Hazards Models; Radiopharmaceuticals; Rituximab; Teniposide; Tomography, X-Ray Computed; Transplantation, Autologous; Treatment Outcome; Vincristine; Young Adult	2010
Standardised uptake value of 18F-FDG on staging PET/CT in newly diagnosed patients with different subtypes of non-Hodgkin's lymphoma. European journal of haematology, 2011, Volume: 86, Issue:1 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity	2011
90Y-ibritumomab tiuxetan as consolidation therapy after autologous stem cell transplantation in aggressive non-Hodgkin lymphoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011, Volume: 52, Issue:6 Topics: Adult; Antibodies, Monoclonal; Antineoplastic Agents; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radioimmunotherapy; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome	2011
[Non-Hodgkin's lymphoma staging: a prospective study of the value of positron emission tomography/computed tomography (PET/CT) versus PET and CT]. Medicina clinica, 2011, Oct-08, Volume: 137, Issue:9 Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Bone Marrow Examination; Contrast Media; Cross-Sectional Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Nuclear Medicine; Observer Variation; Physical Examination; Positron-Emission Tomography; Prospective Studies; Radiology; Radiopharmaceuticals; Reference Standards; Reproducibility of Results; Tomography, X-Ray Computed; Young Adult	2011
Roles and limitations of FDG PET in pediatric non-Hodgkin lymphoma. Clinical nuclear medicine, 2012, Volume: 37, Issue:7 Topics: Adolescent; Adult; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Reference Standards; Remission Induction; Whole Body Imaging; Young Adult	2012
Pre-transplant positron emission tomography (PET) using fluorine-18-fluoro-deoxyglucose (FDG) predicts outcome in patients treated with high-dose chemotherapy and autologous stem cell transplantation for non-Hodgkin's lymphoma. Bone marrow transplantation, 2002, Volume: 30, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Prospective Studies; Remission Induction; Survival Analysis; Survival Rate; Tomography, Emission-Computed; Transplantation, Autologous	2002
Clinical impact of whole body FDG-PET on the staging and therapeutic decision making for malignant lymphoma. Annals of nuclear medicine, 2002, Volume: 16, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Citrates; Decision Making; Female; Fluorodeoxyglucose F18; Gallium; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Care Management; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome; Whole-Body Counting	2002
Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:9 Topics: Annexin A5; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Interpretation, Computer-Assisted; Life Tables; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Organotechnetium Compounds; Radiopharmaceuticals; Reproducibility of Results; Survival Analysis; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed	2002
18FDG PET versus high-dose 67Ga scintigraphy for restaging and treatment follow-up of lymphoma patients. Nuclear medicine communications, 2002, Volume: 23, Issue:11 Topics: Adolescent; Adult; Citrates; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gallium; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed	2002
Early therapy monitoring with FDG-PET in aggressive non-Hodgkin's lymphoma and Hodgkin's lymphoma. European journal of nuclear medicine and molecular imaging, 2004, Volume: 31, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Drug Monitoring; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome	2004
FDG-PET/CT in re-staging of patients with lymphoma. European journal of nuclear medicine and molecular imaging, 2004, Volume: 31, Issue:3 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Enhancement; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prognosis; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Treatment Outcome	2004
18F-FDG PET is superior to 67Ga SPECT in the staging of non-Hodgkin's lymphoma. Annals of nuclear medicine, 2004, Volume: 18, Issue:6 Topics: Citrates; Fluorodeoxyglucose F18; Gallium; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon	2004
Decreased 18F-FDG uptake 1 day after initiation of chemotherapy for malignant lymphomas. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004, Volume: 45, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome	2004
Coincidence imaging using 2 dual-head gamma-camera systems, with and without attenuation correction. Journal of nuclear medicine technology, 2004, Volume: 32, Issue:4 Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gamma Cameras; Gastrointestinal Neoplasms; Humans; Image Enhancement; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Melanoma; Middle Aged; Ovarian Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed	2004
Full-dose 90Y ibritumomab tiuxetan therapy is safe in patients with prior myeloablative chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Oct-01, Volume: 11, Issue:19 Pt 2 Topics: Adult; Age Factors; Aged; Antibodies, Monoclonal; Antigens, CD20; Blood Platelets; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Middle Aged; Platelet Count; Pleural Effusion; Positron-Emission Tomography; Radioimmunotherapy; Recurrence; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes	2005
Early FDG-PET assessment in combination with clinical risk scores determines prognosis in recurring lymphoma. Blood, 2007, Jan-15, Volume: 109, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Remission Induction; Risk Factors; Sensitivity and Specificity; Survival Rate; Transplantation, Autologous; Treatment Outcome	2007
Evaluation of response to fractionated radioimmunotherapy with 90Y-epratuzumab in non-Hodgkin's lymphoma by 18F-fluorodeoxyglucose positron emission tomography. Haematologica, 2008, Volume: 93, Issue:3 Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, Neoplasm; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radioimmunotherapy; Radiopharmaceuticals; Salvage Therapy; Sensitivity and Specificity; Sialic Acid Binding Ig-like Lectin 2; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes	2008
Investigation of FDG-PET/CT imaging to guide biopsies in the detection of histological transformation of indolent lymphoma. Haematologica, 2008, Volume: 93, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Biopsy; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiology, Interventional; Radiopharmaceuticals; Tomography, X-Ray Computed	2008
A prospective study of the separate predictive capabilities of 18[F]-FDG-PET and molecular response in patients with relapsed indolent non-Hodgkin's lymphoma following treatment with iodine-131-rituximab radio-immunotherapy. Haematologica, 2008, Volume: 93, Issue:5 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphoma, Non-Hodgkin; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radioimmunotherapy; Remission Induction; Rituximab; Time Factors; Treatment Outcome	2008
Whole-body positron emission tomography (PET) for diagnosis of residual mass in patients with lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8 Suppl 1 Topics: Adult; Aged; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Tomography, Emission-Computed; Whole-Body Counting	1997
[18F] FDG PET in gastric non-Hodgkin's lymphoma. Acta oncologica (Stockholm, Sweden), 1997, Volume: 36, Issue:6 Topics: Aged; Aged, 80 and over; Endoscopy, Gastrointestinal; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Stomach Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed	1997
Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography. European journal of nuclear medicine, 1998, Volume: 25, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting	1998
Effect of whole-body (18)F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:8 Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Interpretation, Computer-Assisted; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Surveys and Questionnaires; Tomography, Emission-Computed; Whole-Body Counting	2001
Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:6 Topics: Adult; Aged; Bone Marrow; Colon; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Liver; Lung; Lymph Nodes; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Spleen; Tomography, Emission-Computed	2001
Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma. Cancer, 2002, Feb-15, Volume: 94, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed	2002

Other Studies

376 other study(ies) available for fluorodeoxyglucose f18 and Lymphoma, Non-Hodgkin

Article	Year
Case report of an elderly woman with atypical imaging for primary central nervous system lymphoma who needed a brain biopsy for diagnosis. The Journal of international medical research, 2021, Volume: 49, Issue:8 Topics: Aged; Biopsy; Brain; Central Nervous System; Central Nervous System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed	2021
Armor sign on PET-CT in a young male with non-Hodgkin's lymphoma. International journal of hematology, 2022, Volume: 115, Issue:1 Topics: Adult; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Positron Emission Tomography Computed Tomography; Tuberculosis, Pleural; Young Adult	2022
Discordant Metabolic Response on 18F-FDG PET/CT in Synchronous Primary Gastric Lymphoma and Gastric Adenocarcinoma. Clinical nuclear medicine, 2022, Feb-01, Volume: 47, Issue:2 Topics: Adenocarcinoma; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stomach Neoplasms	2022
Prognostic value of FDG-PET/CT response for patient selection before chimeric antigen receptor-T-cells therapy in non-Hodgkin lymphoma. Hematological oncology, 2022, Volume: 40, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Patient Selection; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Receptors, Chimeric Antigen; Retrospective Studies; T-Lymphocytes	2022
[Correlation and Influencing Factors of SUVmax and Ki-67 in Non-Hodgkin Lymphoma]. Zhongguo shi yan xue ye xue za zhi, 2022, Volume: 30, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lymphoma, Non-Hodgkin; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies	2022
Metabolic characteristics and prognostic differentiation of aggressive lymphoma using one-month post-CAR-T FDG PET/CT. Journal of hematology & oncology, 2022, 03-26, Volume: 15, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Immunotherapy, Adoptive; Lymphoma, Non-Hodgkin; Positron Emission Tomography Computed Tomography; Prognosis; Receptors, Chimeric Antigen; Retrospective Studies	2022
Prognostic value of pre-transplantation total metabolic tumor volume on International journal of hematology, 2022, Volume: 116, Issue:4 Topics: Fluorodeoxyglucose F18; Glucose; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Tumor Burden	2022
Primary Breast Lymphoma Mimicking Metastatic Breast Cancer on 18F-FDG PET-CT. JPMA. The Journal of the Pakistan Medical Association, 2022, Volume: 72, Issue:6 Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2022
Lymphoma total lesion glycolysis leads to hyperlactatemia and reduction of brain glucose utilization. Scientific reports, 2022, 07-25, Volume: 12, Issue:1 Topics: Brain; Fluorodeoxyglucose F18; Glucose; Glycolysis; Humans; Hyperlactatemia; Lactates; Lymphoma, Non-Hodgkin; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden	2022
64 Cu-DOTA-Rituximab PET/CT of B-Cell Non-Hodgkin Lymphoma for Imaging the CD20 Expression. Clinical nuclear medicine, 2023, Feb-01, Volume: 48, Issue:2 Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rituximab	2023
Vertebral photopenia on [67Ga]Ga-citrate and [18F]FDG PET/CT imaging in a patient with non-Hodgkin lymphoma. Nuclear medicine review. Central & Eastern Europe, 2023, Volume: 26, Issue:0 Topics: Citrates; Citric Acid; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma, Non-Hodgkin; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2023
Treatment Resulting Changes in Volumes of High- International journal of molecular sciences, 2023, Jan-21, Volume: 24, Issue:3 Topics: Adipose Tissue; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Orbit; Pericardium; Positron Emission Tomography Computed Tomography; Prednisone; Rituximab; Vincristine	2023
Occult optic nerve neurolymphomatosis of T-lymphoblastic lymphoma detected by PET/MRI. British journal of haematology, 2023, Volume: 201, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Neurolymphomatosis; Optic Nerve; Positron-Emission Tomography; Precursor Cell Lymphoblastic Leukemia-Lymphoma	2023
Consolidative radiotherapy for residual fluorodeoxyglucose activity on day +30 post CAR T-cell therapy in non-Hodgkin lymphoma. Haematologica, 2023, 11-01, Volume: 108, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Immunotherapy, Adoptive; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Receptors, Chimeric Antigen; Retrospective Studies	2023
Primary Urethra Non-Hodgkin Lymphoma in a 46-Year-Old Man on FDG PET/CT. Clinical nuclear medicine, 2023, Aug-01, Volume: 48, Issue:8 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Urethra	2023
A hybrid few-shot multiple-instance learning model predicting the aggressiveness of lymphoma in PET/CT images. Computer methods and programs in biomedicine, 2024, Volume: 243 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed	2024
TAC y PET/TC con 18-FDG para evaluar la respuesta al tratamiento en linfoma de Hodgkin y no Hodgkin. Gaceta medica de Mexico, 2019, Volume: 155, Issue:4 Topics: Adolescent; Adult; Aged; Child; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed; Treatment Outcome; Young Adult	2019
Preliminary clinical assessment of dynamic 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for evaluating the clinicopathological grade in patients with non-Hodgkin's lymphoma: a prospective study. Nuclear medicine communications, 2020, Volume: 41, Issue:1 Topics: Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Grading; Positron Emission Tomography Computed Tomography; Prospective Studies; ROC Curve	2020
Modified hydrodissection for percutaneuous biopsy of small lesions: the "marshmallow" technique. Diagnostic and interventional radiology (Ankara, Turkey), 2020, Volume: 26, Issue:1 Topics: Aged; Dissection; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lymph Nodes; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiology, Interventional; Safety	2020
Comparison of clinical and PET-derived prognostic factors in patients with non-Hodgkin lymphoma: a special emphasis on bone marrow involvement. Nuclear medicine communications, 2020, Volume: 41, Issue:6 Topics: Bone Marrow; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Risk; Tumor Burden	2020
Post-heart transplantation lymphoproliferative diseases (PTLDs) and the diagnostic role of [18f] FDG-PET/CT. Minerva medica, 2021, Volume: 112, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Heart Transplantation; Hodgkin Disease; Humans; Hyperplasia; Immunocompromised Host; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Postoperative Complications; Radiopharmaceuticals	2021
Different roles of surveillance positron emission tomography according to the histologic subtype of non-Hodgkin's lymphoma. The Korean journal of internal medicine, 2021, Volume: 36, Issue:Suppl 1 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies	2021
ΔSUVmax for interim PET in DLBCL: old is new. Blood, 2020, 06-18, Volume: 135, Issue:25 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Prognosis	2020
Non-Hodgkin Lymphoma With an Atypical Presentation: A Solitary Paravertebral Mass on FDG PET/CT. Clinical nuclear medicine, 2020, Volume: 45, Issue:11 Topics: Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Positron Emission Tomography Computed Tomography; Spine	2020
18F-FDG PET/computed tomography may predict the outcome of newly diagnosed indolent non-Hodgkin lymphoma in patients managed with initial 'watch-and-wait' approach. Nuclear medicine communications, 2020, Volume: 41, Issue:12 Topics: Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Watchful Waiting	2020
Incidental findings of COVID-19 in F18-FDG PET/CT from asymptomatic patients with cancer in two healthcare institutions in Bogotá, Colombia Biomedica : revista del Instituto Nacional de Salud, 2020, 10-30, Volume: 40, Issue:Supl. 2 Topics: Adult; Aged; Asymptomatic Diseases; Betacoronavirus; Carcinoma, Signet Ring Cell; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms; Pandemics; Pleural Effusion; Pneumonia, Viral; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Seminoma; Stomach Neoplasms	2020
Differentiating gastric cancer and gastric lymphoma using texture analysis (TA) of positron emission tomography (PET). Chinese medical journal, 2020, Nov-18, Volume: 134, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Stomach Neoplasms	2020
High-resolution 18F-FDG PET/MR offers better treatment evaluation than PET/CT or MRI in CNS lymphoma. Japanese journal of clinical oncology, 2021, Apr-30, Volume: 51, Issue:5 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2021
Utility of 18F-FDG-PET/CT in lymphoblastic lymphoma. Leukemia & lymphoma, 2021, Volume: 62, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiopharmaceuticals	2021
Solitary Vulvar Involvement of Ovarian Non-Hodgkin Lymphoma Mimicking Bartholin's Abscess on 18F-FDG PET/CT. Clinical nuclear medicine, 2021, 03-01, Volume: 46, Issue:3 Topics: Abscess; Bartholin's Glands; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Vulva	2021
A Case of Solitary Laryngotracheal Lymphoma Evaluated by 18F-FDG PET/CT. Clinical nuclear medicine, 2021, Aug-01, Volume: 46, Issue:8 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Tracheal Neoplasms	2021
[Prognostic value of interim PET/CT in non-hodgkin lymphoma]. Revista medica de Chile, 2020, Volume: 148, Issue:11 Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed	2020
Role in staging and prognostic value of pretherapeutic F-18 FDG PET/CT in patients with gastric MALT lymphoma without high-grade transformation. Scientific reports, 2021, 04-29, Volume: 11, Issue:1 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Survival Rate; Young Adult	2021
FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials. European journal of nuclear medicine and molecular imaging, 2021, Volume: 48, Issue:11 Topics: Biopsy; Bone Marrow; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Retrospective Studies	2021
Prognostic value of [ European journal of nuclear medicine and molecular imaging, 2021, Volume: 48, Issue:12 Topics: Adenine; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphoma, Non-Hodgkin; Piperidines; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Retrospective Studies; Tumor Burden	2021
The value of bone marrow biopsy for staging of patients with primary CNS lymphoma. Neuro-oncology, 2021, 12-01, Volume: 23, Issue:12 Topics: Biopsy; Bone Marrow; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Staging; Retrospective Studies	2021
Are treatment response assessment maps (TRAMs) and British journal of haematology, 2021, Volume: 195, Issue:1 Topics: Central Nervous System Neoplasms; Cerebellar Neoplasms; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Multimodal Imaging; Neuroimaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2021
Texture Indices of 18F-FDG PET/CT for Differentiating Squamous Cell Carcinoma and Non-Hodgkin's Lymphoma of the Oropharynx. Acta medica Okayama, 2021, Volume: 75, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Oropharyngeal Neoplasms; Positron-Emission Tomography; Retrospective Studies	2021
Targeting personalized medicine in a non-Hodgkin lymphoma patient with 18F-FDG and 18F-choline PET/CT. Revista da Associacao Medica Brasileira (1992), 2017, Volume: 63, Issue:2 Topics: Choline; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms; Sternum	2017
Role of narrow band imaging in the diagnostics of sinonasal pathology. BMJ case reports, 2017, Apr-28, Volume: 2017 Topics: Aged; Diagnosis, Differential; Endoscopy; Fluorodeoxyglucose F18; Humans; Light; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Mediastinum; Mucous Membrane; Narrow Band Imaging; Nasal Cavity; Neck; Neoplasm Invasiveness; Positron Emission Tomography Computed Tomography	2017
Advanced Hodgkin's lymphoma: End-of-treatment FDG-PET should be maintained. European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:8 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals	2017
Diagnosis of secondary peripheral neurolymphomatosis: a multi-center experience. Leukemia & lymphoma, 2017, Volume: 58, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Peripheral Nervous System Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tertiary Care Centers	2017
FDG PET for therapy monitoring in Hodgkin's and non-Hodgkin's lymphomas: qPET versus rPET. European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:9 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography	2017
Adaptive region-growing with maximum curvature strategy for tumor segmentation in Physics in medicine and biology, 2017, Jul-07, Volume: 62, Issue:13 Topics: Algorithms; Calibration; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma, Non-Hodgkin; Phantoms, Imaging; Positron-Emission Tomography	2017
18F-FDG-PET/CT Pulmonary Infiltrates in Non-Hodgkin Lymphoma Patients Treated with Combined Immunochemotherapy: Incidence and Clinical Characteristics. The Israel Medical Association journal : IMAJ, 2017, Volume: 19, Issue:6 Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Incidence; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prednisone; Prospective Studies; Radiopharmaceuticals; Rituximab; Sex Factors; Tomography, X-Ray Computed; Vincristine	2017
Reply to: Laffon and Marthan "FDG PET for therapy monitoring in Hodgkin's and non-Hodgkin's lymphomas: qPET versus rPET". European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:13 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography	2017
A Huge Thoracic Aortic Aneurysm. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2018, Volume: 55, Issue:2 Topics: Aged; Antineoplastic Agents; Aorta, Thoracic; Aortic Aneurysm, Thoracic; Computed Tomography Angiography; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Image-Guided Biopsy; Lymphoma, Non-Hodgkin; Positron-Emission Tomography	2018
Correlation between glycolytic activity on [18F]-FDG-PET and cell density on diffusion-weighted MRI in lymphoma at staging. Journal of magnetic resonance imaging : JMRI, 2018, Volume: 47, Issue:5 Topics: Adult; Aged; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Glucose; Glycolysis; Hodgkin Disease; Humans; Imaging, Three-Dimensional; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Whole Body Imaging	2018
Burkitt non-Hodgkin lymphoma presenting with mental neuropathy ('numb chin' syndrome) in an HIV-positive patient. International journal of STD & AIDS, 2018, Volume: 29, Issue:6 Topics: Adult; Burkitt Lymphoma; Chin; Fluorodeoxyglucose F18; HIV Seropositivity; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography	2018
Value of contrast-enhanced ultrasound and PET/CT in assessment of extramedullary lymphoma. European journal of radiology, 2018, Volume: 99 Topics: Adult; Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; ROC Curve; Tumor Burden; Ultrasonography	2018
PET/CT predicts bone marrow involvement in paediatric non-Hodgkin lymphoma and may preclude the need for bone marrow biopsy in selected patients. European radiology, 2018, Volume: 28, Issue:7 Topics: Adolescent; Adult; Biopsy; Bone Marrow; Bone Marrow Neoplasms; Cell Differentiation; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Lumbar Vertebrae; Lymphoma, Non-Hodgkin; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Young Adult	2018
A Case of Low-Grade Primary Cardiac Lymphoma with Pericardial Effusion Diagnosed by Combined 18F-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography (FDG-PET/CT) Imaging and Effusion Cytology. The American journal of case reports, 2018, Mar-14, Volume: 19 Topics: Aged; Female; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Lymphoma, Non-Hodgkin; Pleural Effusion, Malignant; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Whole Body Imaging	2018
Improving lymph node characterization in staging malignant lymphoma using first-order ADC texture analysis from whole-body diffusion-weighted MRI. Journal of magnetic resonance imaging : JMRI, 2018, Volume: 48, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Reproducibility of Results; Retrospective Studies; ROC Curve; Whole Body Imaging	2018
Challenges of assessing response to therapy in non-Hodgkin's lymphoma of the bone. BMJ case reports, 2018, Apr-17, Volume: 2018 Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dose-Response Relationship, Drug; Fluorodeoxyglucose F18; Humans; Humeral Head; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Osteonecrosis; Positron Emission Tomography Computed Tomography; Remission Induction; Treatment Outcome	2018
18F-FDG PET/MR imaging of lymphoma nodal target lesions: Comparison of PET standardized uptake value (SUV) with MR apparent diffusion coefficient (ADC). Medicine, 2018, Volume: 97, Issue:16 Topics: Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Israel; Lymphoid Tissue; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Observer Variation; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reference Standards; Reproducibility of Results; Retrospective Studies; Tissue Distribution	2018
Usefulness of 18F-FDG PET/CT for evaluating response of ocular adnexal lymphoma to treatment. Medicine, 2018, Volume: 97, Issue:17 Topics: Adult; Aged; Aged, 80 and over; Eye Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms, Adnexal and Skin Appendage; Orbit; Orbital Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome	2018
Annals of nuclear medicine, 2018, Volume: 32, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Treatment Outcome; Tumor Burden; Young Adult	2018
Automated quantification of reference levels in liver and mediastinal blood pool for the Deauville therapy response classification using FDG-PET/CT in Hodgkin and non-Hodgkin lymphomas. Clinical physiology and functional imaging, 2019, Volume: 39, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Automation; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Interpretation, Computer-Assisted; Liver; Lymphoma, Non-Hodgkin; Male; Mediastinum; Middle Aged; Neural Networks, Computer; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Treatment Outcome; Young Adult	2019
False positive finding of F18-FDG in non-Hodgkins lymphoma; an inflamed appendix. JPMA. The Journal of the Pakistan Medical Association, 2018, Volume: 68, Issue:6 Topics: Adult; Appendectomy; Appendicitis; Diagnostic Errors; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2018
Predictive Value of FDG PET/CT Versus Bone Marrow Biopsy in Pediatric Lymphoma. Clinical nuclear medicine, 2018, Volume: 43, Issue:12 Topics: Adolescent; Bone Marrow; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals	2018
The clinical value of imaging in primary cutaneous lymphomas: Role of high resolution ultrasound and PET-CT. The British journal of radiology, 2019, Volume: 92, Issue:1095 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Skin; Skin Neoplasms; Ultrasonography; Young Adult	2019
Fluorodeoxyglucose Detected Changes in Brain Metabolism After Chemotherapy in Pediatric Non-Hodgkin Lymphoma. Pediatric neurology, 2019, Volume: 92 Topics: Adolescent; Antineoplastic Agents; Brain; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Remission Induction; Retrospective Studies	2019
Role of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Predicting the Adverse Effects of Chimeric Antigen Receptor T Cell Therapy in Patients with Non-Hodgkin Lymphoma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2019, Volume: 25, Issue:6 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy, Adoptive; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult	2019
High-grade B-cell lymphoma relapse presenting as neurolymphomatosis of the median nerve. BMJ case reports, 2019, Mar-06, Volume: 12, Issue:3 Topics: Aged; Arm; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Median Nerve; Neurolymphomatosis; Positron-Emission Tomography; Radiotherapy; Ultrasonography; Ultrasonography, Doppler, Duplex	2019
Incidental finding of non-Hodgkin's lymphoma in a patient affected by castration-sensitive prostate cancer: A case report. Medicine, 2019, Volume: 98, Issue:11 Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Acinar Cell; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Neoplasm Grading; Neoplasm Staging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Prednisone; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Rituximab; Tomography, X-Ray Computed; Treatment Outcome; Triptorelin Pamoate; Vincristine	2019
Postchemotherapy Histiocyte-Rich Pseudotumor of the Spleen Simulating Residual Disease in a Patient With Non-Hodgkin Lymphoma on FDG PET/CT. Clinical nuclear medicine, 2019, Volume: 44, Issue:6 Topics: Antineoplastic Agents; Diagnosis, Differential; Fluorodeoxyglucose F18; Granuloma, Plasma Cell; Histiocytes; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Spleen	2019
Can Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Predict Chimeric Antigen Receptor T Cell Adverse Effects? Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2019, Volume: 25, Issue:6 Topics: Cell- and Tissue-Based Therapy; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Multimodal Imaging; Positron-Emission Tomography; Receptors, Chimeric Antigen; T-Lymphocytes	2019
Evidence for a cardiac metabolic switch in patients with Hodgkin's lymphoma. ESC heart failure, 2019, Volume: 6, Issue:4 Topics: Adult; Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Glucose; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Muscle, Skeletal; Myocardium; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies	2019
Prognostic significance of pretreatment ¹⁸F-FDG PET/CT in patients with relapsed/refractory B-cell non-Hodgkin's lymphoma treated by radioimmunotherapy using ¹³¹I-rituximab. Acta haematologica, 2013, Volume: 130, Issue:2 Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Staging; Odds Ratio; Positron-Emission Tomography; Prognosis; Radioimmunotherapy; Radiopharmaceuticals; Recurrence; Rituximab; Tomography, X-Ray Computed	2013
High FDG activity in focal fat necrosis: a pitfall in interpretation of posttreatment PET/CT in patients with non-Hodgkin lymphoma. European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:9 Topics: Adult; Aged; False Positive Reactions; Fat Necrosis; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2013
The use of interim (18)F-fluorodeoxyglucose PET to guide therapy in lymphoma. Future oncology (London, England), 2013, Volume: 9, Issue:6 Topics: Clinical Trials as Topic; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Prognosis; Radiography; Treatment Outcome	2013
Primary ovarian non-Hodgkin's lymphoma. BMJ case reports, 2013, Jul-29, Volume: 2013 Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals	2013
Beta-2 microglobulin as a diagnostic parameter in non-Hodgkin lymphoma: a comparative study with FDG-PET. Anticancer research, 2013, Volume: 33, Issue:8 Topics: beta 2-Microglobulin; Biomarkers, Tumor; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Reference Standards	2013
Interim PET response criteria in paediatric non-Hodgkin's lymphoma. Results from a retrospective multicenter reading. Nuklearmedizin. Nuclear medicine, 2013, Volume: 52, Issue:4 Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Germany; Humans; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Young Adult	2013
[Prognostic significance of 18F-FDG PET/CT in aggressive non- Hodgkin's lymphoma: a 10-year retrospective study on 105 cases]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2013, Volume: 34, Issue:8 Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Analysis	2013
Standardized uptake value based evaluation of lymphoma by FDG and FLT PET/CT. Hematological oncology, 2014, Volume: 32, Issue:3 Topics: Adolescent; Adult; Aged; Child; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed; Young Adult	2014
Patterns of FDG uptake in pancreatic non-Hodgkin's lymphoma lesions. Abdominal imaging, 2014, Volume: 39, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies	2014
Focal and diffuse FDG uptake patterns of endotracheal lymphoma. Clinical nuclear medicine, 2014, Volume: 39, Issue:8 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Leukemic Infiltration; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Trachea	2014
Early determination of prognosis by interim 3'-deoxy-3'-18F-fluorothymidine PET in patients with non-Hodgkin lymphoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Recurrence; ROC Curve; Thymine; Treatment Outcome	2014
Successful surgical treatment for pulmonary crystal-storing histiocytosis following the onset of gastric non-hodgkin lymphoma. Journal of clinical and experimental hematopathology : JCEH, 2013, Volume: 53, Issue:3 Topics: Aged, 80 and over; Fluorodeoxyglucose F18; Gene Rearrangement; Histiocytes; Histiocytosis; Humans; Immunoglobulin Heavy Chains; Immunoglobulins; Immunohistochemistry; Lung; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Solitary Pulmonary Nodule; Stomach Neoplasms; Treatment Outcome	2013
[Comparison of ¹⁸F-FDG PET/CT and large-scale DWI for evaluation of non-Hodgkin lymphoma bone marrow infiltration]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2014, Volume: 35, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult	2014
A prospective study of ¹⁸FDG-PET with CT coregistration for radiation treatment planning of lymphomas and other hematologic malignancies. International journal of radiation oncology, biology, physics, 2014, Jun-01, Volume: 89, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hematologic Neoplasms; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasms, Plasma Cell; Nuclear Physics; Positron-Emission Tomography; Prospective Studies; Radiation Oncology; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Recurrence; Tomography, X-Ray Computed; Tumor Burden; Young Adult	2014
Evaluation of primary bone lymphoma and the importance of positron emission tomography. Acta orthopaedica et traumatologica turcica, 2014, Volume: 48, Issue:3 Topics: Adolescent; Biopsy; Bone Neoplasms; Chemoradiotherapy; Child; Femoral Neoplasms; Fibula; Fluorodeoxyglucose F18; Humans; Ilium; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Remission Induction; Reproducibility of Results; Sensitivity and Specificity	2014
Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Sep-20, Volume: 32, Issue:27 Topics: Bone Marrow Neoplasms; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; International Cooperation; Liver Neoplasms; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome	2014
[Synchronous hepatocellular carcinoma and B-cell non-Hodgkin's lymphoma in chronic hepatitis C patient]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2014, Sep-25, Volume: 64, Issue:3 Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Embolization, Therapeutic; Fluorodeoxyglucose F18; Gadolinium DTPA; Genotype; Hepatitis B virus; Hepatitis C, Chronic; Humans; Liver Neoplasms; Lymph Nodes; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed	2014
Epiphyseal presentation of non-Hodgkin's lymphoma of bone in two pediatric patients--one with primary lymphoma of bone. Skeletal radiology, 2015, Volume: 44, Issue:4 Topics: Adolescent; Biopsy; Child; Diagnosis, Differential; Epiphyses; Femur; Fluorodeoxyglucose F18; Humans; Knee; Lymphoma; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome	2015
[A clinical analysis of 40 cases of primary and secondary pulmonary lymphoma]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2014, Volume: 37, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymph Nodes; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mediastinum; Middle Aged; Prognosis; Retrospective Studies; Thorax; Tomography, X-Ray Computed; Young Adult	2014
Pretransplantation fluorine-18-deoxyglucose-positron emission tomography scan has no influence on relapse and survival in non-Hodgkin lymphoma patients undergoing allo-SCT. Bone marrow transplantation, 2015, Volume: 50, Issue:1 Topics: Adolescent; Adult; Aged; Allografts; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Stem Cell Transplantation; Survival Rate	2015
The role of FDG-PET/CT in the evaluation of residual disease in paediatric non-Hodgkin lymphoma. British journal of haematology, 2015, Volume: 168, Issue:6 Topics: Adolescent; Biopsy; Child; Child, Preschool; Disease Progression; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Multimodal Imaging; Neoplasm, Residual; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult	2015
Positron emission tomography-computed tomography in follicular lymphoma: "one fit for all"? Leukemia & lymphoma, 2015, Volume: 56, Issue:5 Topics: Antibodies, Monoclonal, Murine-Derived; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography	2015
Complementary roles of bone scintigraphy and MR imaging in the detection and long-term follow-up of primary non-Hodgkin's bone lymphoma in a child-case report. Skeletal radiology, 2015, Volume: 44, Issue:6 Topics: Adolescent; Female; Femoral Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Longitudinal Studies; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals	2015
Detection of non-Hodgkin lymphoma by [¹⁸F]FDG-PET/CT in a patient with differentiated thyroid cancer. Endocrine, 2015, Volume: 50, Issue:1 Topics: Adult; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Multimodal Imaging; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms	2015
[Metabolic activity measured by ¹⁸F-FDG PET/CT in newly diagnosed patients with non-Hodgkin lymphoma: correlation with immunophenotype]. Zhonghua yi xue za zhi, 2014, Sep-09, Volume: 94, Issue:33 Topics: Fluorodeoxyglucose F18; Humans; Immunophenotyping; Lymphoma, Non-Hodgkin; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed	2014
Paget's disease of the bone mimicking lymphomatous bone marrow involvement at FDG-PET. American journal of hematology, 2015, Volume: 90, Issue:3 Topics: Aged; Bone Marrow; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Osteitis Deformans; Positron-Emission Tomography; Radiography	2015
Diffusely increased bone marrow FDG uptake in recently untreated lymphoma: incidence and relevance. European journal of haematology, 2015, Volume: 95, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Biopsy; Bone Marrow; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies	2015
Deriving global quantitative tumor response parameters from 18F-FDG PET-CT scans in patients with non-Hodgkin's lymphoma. Nuclear medicine communications, 2015, Volume: 36, Issue:4 Topics: Disease Progression; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma, Non-Hodgkin; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Burden	2015
High liver FDG uptake on PET/CT in patient with lymphoma diagnosed with hereditary hemochromatosis. Clinical nuclear medicine, 2015, Volume: 40, Issue:6 Topics: Fluorodeoxyglucose F18; Hemochromatosis; Humans; Liver; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
Do not abandon the bone marrow biopsy yet in diffuse large B-cell lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Apr-01, Volume: 33, Issue:10 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
Value of positron emission tomography in diagnosing subcutaneous panniculitis-like T-cell lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Apr-01, Volume: 33, Issue:10 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
Evaluation of Diffusion-Weighted Magnetic Resonance Imaging for Follow-up and Treatment Response Assessment of Lymphoma: Results of an 18F-FDG-PET/CT-Controlled Prospective Study in 64 Patients. Clinical cancer research : an official journal of the American Association for Cancer Research, 2015, Jun-01, Volume: 21, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiography; Whole Body Imaging	2015
Diagnosis, PET/CT imaging, and treatment of extranodal non-Hodgkin lymphoma in keratinized gingiva: a case report. Journal of oral science, 2015, Volume: 57, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Diabetes Mellitus, Type 2; Fluorodeoxyglucose F18; Gingival Neoplasms; Humans; Immunohistochemistry; Keratins; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Oral Surgical Procedures; Positron Emission Tomography Computed Tomography; Radiography, Panoramic; Radiopharmaceuticals	2015
The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. Accuracy in a multicenter series of 372 patients. American journal of hematology, 2015, Volume: 90, Issue:8 Topics: Adolescent; Adult; Aged; Biopsy; Bone Marrow; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed	2015
Prognostic Value of FDG PET/CT before Allogeneic and Autologous Stem Cell Transplantation for Aggressive Lymphoma. Radiology, 2015, Volume: 277, Issue:2 Topics: Adolescent; Adult; Aged; Child; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiography; Radiopharmaceuticals; Retrospective Studies; Stem Cell Transplantation; Survival Rate; Treatment Outcome	2015
Primary Central Nervous System Natural Killer Cell Lymphoma in a Chinese Woman with Atypical (11)C-Choline Positron Emission Tomography and Magnetic Resonance Spectrometry Findings. World neurosurgery, 2015, Volume: 84, Issue:4 Topics: Adult; Central Nervous System Neoplasms; Choline; Female; Fluorodeoxyglucose F18; Glioma; Humans; Killer Cells, Natural; Lymphoma, Non-Hodgkin; Magnetic Resonance Spectroscopy; Neurosurgical Procedures; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome	2015
Whole-body diffusion-weighted MRI and (18)F-FDG PET/CT can discriminate between different lymphoma subtypes. Clinical radiology, 2015, Volume: 70, Issue:11 Topics: Adolescent; Adult; Aged; Analysis of Variance; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult	2015
Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients. European journal of nuclear medicine and molecular imaging, 2015, Volume: 42, Issue:13 Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Lymphoma, Non-Hodgkin; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals	2015
Baseline and ongoing PET-derived factors predict detrimental effect or potential utility of 18F-FDG PET/CT (FDG-PET/CT) performed for surveillance in asymptomatic lymphoma patients in first remission. European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:2 Topics: Adolescent; Adult; Aged; Asymptomatic Diseases; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Tomography, X-Ray Computed	2016
The Role of FDG-PET in the Diagnosis and Staging of Ocular Adnexal Lymphoproliferative Disease. Orbit (Amsterdam, Netherlands), 2015, Volume: 34, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Orbital Diseases; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed	2015
[PET/CT Image Values in Clinical Staging of the Patients with Non-Hodgkin's Lymphoma]. Zhongguo shi yan xue ye xue za zhi, 2015, Volume: 23, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed	2015
Role of WB-MR/DWIBS compared to (18)F-FDG PET/CT in the therapy response assessment of lymphoma. La Radiologia medica, 2016, Volume: 121, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging; Young Adult	2016
Primary tracheal and bronchial lymphoma displayed on 18F-FDG PET/CT imaging. Clinical nuclear medicine, 2015, Volume: 40, Issue:12 Topics: Bronchial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tracheal Neoplasms	2015
Neurolymphomatosis on 18F-FDG PET/CT: Diagnosis and Therapy Response. Clinical nuclear medicine, 2016, Volume: 41, Issue:2 Topics: Adult; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Multimodal Imaging; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2016
Follow-up FDG PET/CT in Patients With Non-Hodgkin Lymphoma: Value to Clinical Assessment and Patient Management. Clinical nuclear medicine, 2016, Volume: 41, Issue:2 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2016
Detection of Leptomeningeal Involvement by 18F-FDG-PET/CT in a Patient With Non-Hodgkin Lymphoma. Clinical nuclear medicine, 2016, Volume: 41, Issue:2 Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Meningeal Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2016
False-Positive 18F-FDG PET/CT Imaging: Dramatic "Flare Response" After Rituximab Administration. Clinical nuclear medicine, 2016, Volume: 41, Issue:3 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Methylprednisolone; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rituximab; Tomography, X-Ray Computed	2016
18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging. Investigative radiology, 2016, Volume: 51, Issue:3 Topics: Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Interpretation, Computer-Assisted; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2016
Massive Pelvic Lymphadenopathy Due to Recurrent Non-Hodgkin Lymphoma Incidentally Revealed on a 99mTc-MDP Bone Scintigraphy. Clinical nuclear medicine, 2016, Volume: 41, Issue:6 Topics: Bone and Bones; Fluorodeoxyglucose F18; Humans; Lymphadenopathy; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Pelvis; Positron Emission Tomography Computed Tomography; Radionuclide Imaging; Radiopharmaceuticals; Scrotum; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Urinary Bladder	2016
The value of fourth and subsequent post-treatment 18F-FDG PET/CT scans in the management of patients with non-Hodgkin's lymphoma. Nuclear medicine communications, 2016, Volume: 37, Issue:7 Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome	2016
Coincidental Observation of Global Hypometabolism in the Brain on PET/CT of an AIDS Patient With High-Grade Pulmonary Non-Hodgkin Lymphoma. Clinical nuclear medicine, 2016, Volume: 41, Issue:8 Topics: AIDS Dementia Complex; Brain; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2016
Hybrid FDG-PET/MR compared to FDG-PET/CT in adult lymphoma patients. Abdominal radiology (New York), 2016, Volume: 41, Issue:7 Topics: Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Interpretation, Computer-Assisted; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2016
18F-FDG PET Detection of a Medullary Thyroid Carcinoma in a Patient With SMZL. Clinical nuclear medicine, 2016, Volume: 41, Issue:10 Topics: Aged, 80 and over; Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Positron Emission Tomography Computed Tomography; Splenic Neoplasms; Thyroid Neoplasms	2016
CT-based texture analysis potentially provides prognostic information complementary to interim fdg-pet for patients with hodgkin's and aggressive non-hodgkin's lymphomas. European radiology, 2017, Volume: 27, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Tomography, X-Ray Computed; Young Adult	2017
Prognostic value of SUVmax measured by pretreatment 18F-FDG PET/CT in patients with primary gastric lymphoma. Nuclear medicine communications, 2016, Volume: 37, Issue:12 Topics: Adult; Aged; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Kaplan-Meier Estimate; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms	2016
Synchronous or metachronous lymphoma and metastatic cutaneous squamous cell carcinoma in the head and neck region: a diagnostic and management dilemma. The Journal of laryngology and otology, 2016, Volume: 130 Suppl 4 Topics: Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Positron-Emission Tomography	2016
Interim PET-CT Scan in Advanced Hodgkin's Lymphoma. The New England journal of medicine, 2016, 09-08, Volume: 375, Issue:10 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Tomography, X-Ray Computed	2016
Interim PET-CT Scan in Advanced Hodgkin's Lymphoma. The New England journal of medicine, 2016, 09-08, Volume: 375, Issue:10 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Tomography, X-Ray Computed	2016
Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in Lymphoma. Clinical nuclear medicine, 2017, Volume: 42, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Marrow Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Splenic Neoplasms; Young Adult	2017
(18)F-fluorodeoxyglucose positron emission tomography/computed tomography comparison of gastric lymphoma and gastric carcinoma. World journal of gastroenterology, 2016, Sep-14, Volume: 22, Issue:34 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Child; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; ROC Curve; Stomach Neoplasms; Young Adult	2016
High-risk interim PET negative patients in Hodgkin's lymphoma. The Lancet. Haematology, 2016, Volume: 3, Issue:10 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed	2016
Evaluation of decreased uptake of 18F-fluorodeoxyglucose in the cerebral cortex of patients with intracranial non-Hodgkin's lymphoma lesions through PET/CT. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2016, Volume: 84 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Basal Ganglia; Cerebral Cortex; Child; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Young Adult	2016
Pediatric Brown Adipose Tissue on Journal of nuclear medicine technology, 2017, Volume: 45, Issue:2 Topics: Adipose Tissue, Brown; Adolescent; Artifacts; Biological Transport; Diazepam; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Retrospective Studies	2017
[ Cancer, 2017, Aug-01, Volume: 123, Issue:15 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Disease Management; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Ontario; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Registries; Young Adult	2017
A possible role of 18F-FDG positron-emission tomography scanning in the early detection of rituximab-induced pneumonitis in patients with non-Hodgkin's lymphoma. Haematologica, 2008, Volume: 93, Issue:8 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Fluorodeoxyglucose F18; Lymphoma, Non-Hodgkin; Pneumonia; Positron-Emission Tomography; Radiopharmaceuticals; Rituximab	2008
New staging and response criteria for non-Hodgkin lymphoma and Hodgkin lymphoma. Radiologic clinics of North America, 2008, Volume: 46, Issue:2 Topics: Clinical Trials as Topic; Disease Progression; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Tomography, X-Ray Computed	2008
Clinical significance of axillary findings in patients with lymphoma during follow-up with 18F-fluorodeoxyglucose-PET. Nuclear medicine communications, 2008, Volume: 29, Issue:8 Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Retrospective Studies; Ultrasonography	2008
Primary multifocal osseous lymphoma in a child. Pediatric radiology, 2008, Volume: 38, Issue:12 Topics: Arthralgia; Biopsy; Bone Neoplasms; Child; Diagnosis, Differential; Female; Femur; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rare Diseases; Tomography, X-Ray Computed; Whole Body Imaging	2008
PET/CT appearance of non-Hodgkin lymphoma of the vermiform appendix. Clinical nuclear medicine, 2008, Volume: 33, Issue:10 Topics: Appendix; Cecal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2008
The utility of 18-F-fluorodeoxyglucose positron emission tomography in evaluation of bone marrow involvement by non-Hodgkin lymphoma. American journal of clinical oncology, 2008, Volume: 31, Issue:5 Topics: Adult; Aged; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies	2008
High incidence of false-positive PET scans in patients with aggressive non-Hodgkin's lymphoma treated with rituximab-containing regimens. Annals of oncology : official journal of the European Society for Medical Oncology, 2009, Volume: 20, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Recurrence; Retrospective Studies; Rituximab; Sensitivity and Specificity; Survival Analysis; Vincristine; Young Adult	2009
[18F]fluorodeoxyglucose positron emission tomography in the management of lymphomas. Clinical lymphoma & myeloma, 2008, Volume: 8, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Time Factors	2008
Positron emission tomography changes management, improves prognostic stratification and is superior to gallium scintigraphy in patients with low-grade lymphoma: results of a multicentre prospective study. European journal of nuclear medicine and molecular imaging, 2009, Volume: 36, Issue:3 Topics: Disease-Free Survival; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed	2009
Drug-induced pneumonitis detected earlier by 18F-FDG-PET than by high-resolution CT: a case report with non-Hodgkin's lymphoma. Annals of nuclear medicine, 2008, Volume: 22, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pneumonia; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Vincristine	2008
(18)F-FDG PET in Pediatric Lymphomas: A Comparison with Conventional Imaging. Cancer biotherapy & radiopharmaceuticals, 2008, Volume: 23, Issue:6 Topics: Adolescent; Child; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Neoplasm Staging; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2008
Diffuse skeletal muscle F-18 fluorodeoxyglucose uptake in advanced primary muscle non-Hodgkin's lymphoma. Clinical nuclear medicine, 2009, Volume: 34, Issue:4 Topics: Aged; Disease Progression; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Muscle Neoplasms; Muscle, Skeletal; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2009
Dual-time F-18 FDG-PET/CT imaging for diagnosis of occult non-Hodgkin lymphoma in a patient with esophageal cancer. Clinical nuclear medicine, 2009, Volume: 34, Issue:3 Topics: Adenocarcinoma; Aged; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed	2009
Standardized uptake value on FDG-PET as a marker for disease activity in patients with non-Hodgkin's lymphoma: comparison with serum soluble interleukin-2 receptor values. International journal of clinical oncology, 2009, Volume: 14, Issue:2 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Interleukin-2	2009
Tumor metabolic phenotypes on 18F FDG PET. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2009, Volume: 50, Issue:6 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Phenotype; Positron-Emission Tomography; Radiopharmaceuticals	2009
[18F]-fluorodeoxyglucose positron emission tomography combined with computed tomography detection of asymptomatic late pulmonary toxicity in patients with non-Hodgkin lymphoma treated with rituximab-containing chemotherapy. Leukemia & lymphoma, 2009, Volume: 50, Issue:6 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Retrospective Studies; Rituximab; Tomography, X-Ray Computed	2009
Incidental findings on follow-up fluorodeoxyglucose positron emission tomography studies in lymphoma patients: beware the outlier. Leukemia & lymphoma, 2009, Volume: 50, Issue:6 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung; Lung Diseases; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Rituximab; Tomography, X-Ray Computed	2009
Quantification of local tumor response to fractionated radiation therapy for non-Hodgkin lymphoma using weekly 18F-FDG PET/CT imaging. International journal of radiation oncology, biology, physics, 2010, Mar-01, Volume: 76, Issue:3 Topics: Dose Fractionation, Radiation; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Remission Induction; Time Factors; Tomography, X-Ray Computed; Tumor Burden	2010
Glut1 and Glut3 expression in lymphoma and their association with tumor intensity on 18F-fluorodeoxyglucose positron emission tomography. Nuclear medicine communications, 2009, Volume: 30, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Glucose Transporter Type 3; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography	2009
[18F-FDG uptake of lymphoma lesions of various histological subtypes]. Ai zheng = Aizheng = Chinese journal of cancer, 2009, Volume: 28, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Ki-67 Antigen; Lymphoma, B-Cell; Lymphoma, Extranodal NK-T-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult	2009
Non-Hodgkin's lymphoma of supraclavicular lymph nodes can mimic metastasis of breast cancer during chemotherapy on FDG PET/CT. Clinical nuclear medicine, 2009, Volume: 34, Issue:9 Topics: Adult; Breast Neoplasms; Clavicle; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed	2009
Intraspinal canal neurolymphomatosis detected by FDG-PET/CT. Clinical nuclear medicine, 2009, Volume: 34, Issue:9 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Spinal Canal; Tomography, X-Ray Computed	2009
On the added value of baseline FDG-PET in malignant lymphoma. Molecular imaging and biology, 2010, Volume: 12, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Whole Body Imaging; Young Adult	2010
Expert opinions on positron emission tomography and computed tomography imaging in lymphoma. The oncologist, 2009, Volume: 14 Suppl 2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome	2009
Pre-therapy 18F-FDG PET quantitative parameters help in predicting the response to radioimmunotherapy in non-Hodgkin lymphoma. European journal of nuclear medicine and molecular imaging, 2010, Volume: 37, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Fuzzy Logic; Glycolysis; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radioimmunotherapy; Retrospective Studies; Treatment Outcome; Tumor Burden	2010
18F-FDG PET/CT in primary non-Hodgkin's lymphoma of the sinonasal tract. Annals of hematology, 2010, Volume: 89, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Organoplatinum Compounds; Paranasal Sinus Neoplasms; Paranasal Sinuses; Positron-Emission Tomography; Prednisone; Prognosis; Remission Induction; Tomography, Emission-Computed; Vincristine	2010
Late FDG PET normalization after radioimmunotherapy in a patient with non-Hodgkin lymphoma. Clinical nuclear medicine, 2009, Volume: 34, Issue:11 Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Positron-Emission Tomography; Radioimmunotherapy	2009
Biliary non-Hodgkin lymphoma detected by F-18 FDG PET/CT. Clinical nuclear medicine, 2009, Volume: 34, Issue:11 Topics: Biliary Tract Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed	2009
Interim positron emission tomography scan in multi-center studies: optimization of visual and quantitative assessments. Leukemia & lymphoma, 2009, Volume: 50, Issue:11 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Multicenter Studies as Topic; Netherlands; Positron-Emission Tomography; Prognosis; Reference Standards; Treatment Outcome	2009
False-positive F-18 FDG uptake in PET/CT studies in pediatric patients with abdominal Burkitt's lymphoma. Nuclear medicine communications, 2010, Volume: 31, Issue:3 Topics: Burkitt Lymphoma; Child; Child, Preschool; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Necrosis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed	2010
Post-therapy calcification can result in false-positive fluorodeoxyglucose positron emission tomography scans in patients with non-Hodgkin's lymphoma. Leukemia & lymphoma, 2010, Volume: 51, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Calcinosis; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymphatic Diseases; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Young Adult	2010
SUVmax in FDG-PET at the biopsy site correlates with the proliferation potential of tumor cells in non-Hodgkin lymphoma. Leukemia & lymphoma, 2010, Volume: 51, Issue:2 Topics: Biopsy; Cell Proliferation; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lymph Nodes; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Sensitivity and Specificity	2010
Using positron emission tomography to assess tumor proliferation in non-Hodgkin lymphoma. Leukemia & lymphoma, 2010, Volume: 51, Issue:2 Topics: Biopsy; Cell Proliferation; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lymph Nodes; Lymphoma, Non-Hodgkin; Positron-Emission Tomography	2010
FDG PET/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease. Radiographics : a review publication of the Radiological Society of North America, Inc, 2010, Volume: 30, Issue:1 Topics: Adult; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Young Adult	2010
The role of PET-CT in the differential diagnosis of thymic mass after treatment of patients with lymphoma. Medical oncology (Northwood, London, England), 2011, Volume: 28, Issue:1 Topics: Adolescent; Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Tomography, X-Ray Computed; Young Adult	2011
A case of advanced non-Hodgkin's lymphoma involving the prostate: staging and treatment monitoring using F-18 FDG PET/CT imaging. Clinical nuclear medicine, 2010, Volume: 35, Issue:6 Topics: Adult; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed; Treatment Outcome	2010
Primary spinal epidural non-Hodgkin lymphoma demonstrated by FDG PET/CT. Clinical nuclear medicine, 2010, Volume: 35, Issue:7 Topics: Adult; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Spinal Cord Neoplasms; Tomography, X-Ray Computed	2010
Rituximab-induced pneumonitis on F-18 FDG PET/CT in patient with non-Hodgkin lymphoma. Clinical nuclear medicine, 2010, Volume: 35, Issue:8 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Pneumonia; Positron-Emission Tomography; Rituximab; Tomography, X-Ray Computed	2010
Pretransplantation [18-F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell transp Cancer, 2010, Nov-01, Volume: 116, Issue:21 Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Graft vs Host Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Recurrence; Retrospective Studies; Stem Cell Transplantation; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome	2010
The role of routine imaging procedures in the detection of relapse of patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma. Annals of hematology, 2011, Volume: 90, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Remission Induction; Survival Rate; Tomography, X-Ray Computed; Young Adult	2011
Osteonecrosis in an adolescent with non-Hodgkin lymphoma resembling a new metastatic lesion on (18)F-FDG PET/CT. Pediatric radiology, 2010, Volume: 40 Suppl 1 Topics: Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Osteonecrosis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult	2010
Decreased brain FDG uptake in patients with extensive non-Hodgkin's lymphoma lesions. Annals of nuclear medicine, 2010, Volume: 24, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Brain; Female; Fluorodeoxyglucose F18; Glucose; Glycolysis; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden	2010
Unexpected primary osseous lymphoma as the cause of lactic acidosis in a patient suffering from pancreatitis. Clinical nuclear medicine, 2010, Volume: 35, Issue:10 Topics: Acidosis, Lactic; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pancreatitis; Positron-Emission Tomography; Tomography, X-Ray Computed	2010
Early post transplant (F-18) 2-fluoro-2-deoxyglucose positron emission tomography does not predict outcome for patients undergoing auto-SCT in non-Hodgkin and Hodgkin lymphoma. Bone marrow transplantation, 2011, Volume: 46, Issue:6 Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; Time Factors; Transplantation, Autologous; Treatment Outcome; Young Adult	2011
[¹⁸F]FDG-positron emission tomography coregistration with computed tomography scans for radiation treatment planning of lymphoma and hematologic malignancies. International journal of radiation oncology, biology, physics, 2011, Nov-01, Volume: 81, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Cancer Care Facilities; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasms, Plasma Cell; New York City; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden; Young Adult	2011
Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma. Cancer, 2011, Mar-01, Volume: 117, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoxantrone; Monitoring, Physiologic; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Retrospective Studies; Rituximab; Survival Analysis; Time Factors; Vincristine; Young Adult	2011
Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2011, Volume: 55, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2011
Features of large cell transformation of indolent lymphomas as observed on sequential PET/CT. Nuclear medicine communications, 2011, Volume: 32, Issue:3 Topics: Biological Transport; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed	2011
Sagittal sinus tumor thrombosis in a case of NHL demonstrated on F-18 FDG PET/CT. Clinical nuclear medicine, 2011, Volume: 36, Issue:3 Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Positron-Emission Tomography; Sagittal Sinus Thrombosis; Tomography, X-Ray Computed	2011
FDG PET/CT leads to the detection of metastatic involvement of the heart in non-Hodgkin's lymphoma. European journal of nuclear medicine and molecular imaging, 2011, Volume: 38, Issue:6 Topics: Female; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult	2011
Fluorodeoxyglucose uptake in the bone marrow after granulocyte colony-stimulating factor administration in patients with non-Hodgkin's lymphoma. Nuclear medicine communications, 2011, Volume: 32, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Bone Marrow; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Spine; Time Factors; Young Adult	2011
Biopsy versus FDG PET/CT in the initial evaluation of bone marrow involvement in pediatric lymphoma patients. European journal of nuclear medicine and molecular imaging, 2011, Volume: 38, Issue:8 Topics: Adolescent; Bone Marrow Neoplasms; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult	2011
Determining the extent and stage of disease in patients with newly diagnosed non-Hodgkin's lymphoma using 18F-FDG-PET/CT. Neoplasma, 2011, Volume: 58, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2011
Use of F-18 FDG PET/CT in non-Hodgkin lymphoma with central nervous system involvement. Clinical nuclear medicine, 2011, Volume: 36, Issue:6 Topics: Central Nervous System Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed	2011
Synchronous second primary neoplasms detected by initial staging F-18 FDG PET/CT examination in patients with non-Hodgkin lymphoma. Clinical nuclear medicine, 2011, Volume: 36, Issue:7 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Tomography, X-Ray Computed	2011
Kikuchi-Fujimoto disease: PET/CT assessment of a rare cause of cervical lymphadenopathy. Clinical nuclear medicine, 2011, Volume: 36, Issue:8 Topics: Adolescent; Adult; Biological Transport; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Histiocytic Necrotizing Lymphadenitis; Humans; Lymphatic Diseases; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Diseases	2011
Can fluorodeoxyglucose positron emission tomography/computed tomography avoid negative iliac crest biopsies in evaluation of marrow involvement by lymphoma at time of initial staging? Leukemia & lymphoma, 2011, Volume: 52, Issue:11 Topics: Algorithms; Biopsy; Bone Marrow; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Ilium; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed	2011
Comparison of CT, PET, and PET/CT for staging of patients with indolent non-hodgkin's lymphoma: statistical errors in Fueger et al. (2009). Molecular imaging and biology, 2012, Volume: 14, Issue:4 Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2012
Diffuse skeletal muscles uptake of [18F] fluorodeoxyglucose on positron emission tomography in primary muscle peripheral T-cell lymphoma. Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:18 Topics: Adult; Biological Transport; Biopsy; Fluorodeoxyglucose F18; Humans; Immunophenotyping; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Magnetic Resonance Imaging; Male; Muscle, Skeletal; Positron-Emission Tomography	2011
Evaluation of PET volume segmentation methods: comparisons with expert manual delineations. Nuclear medicine communications, 2012, Volume: 33, Issue:1 Topics: Algorithms; Fluorodeoxyglucose F18; Fuzzy Logic; Humans; Image Processing, Computer-Assisted; Lymphoma, Non-Hodgkin; Observer Variation; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity	2012
Demonstration of peripheral nerve root involvement by non-Hodgkin's lymphoma on 18F-FDG PET/CT. European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:4 Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Multimodal Imaging; Peripheral Nerves; Positron-Emission Tomography; Tomography, X-Ray Computed	2012
Aggressive non-Hodgkin's lymphoma mimicking unilateral transitional cell carcinoma of renal pelvis. The risk of making a diagnostic mistake. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2011, Volume: 83, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Diagnosis, Differential; Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Incidental Findings; Kidney Neoplasms; Kidney Pelvis; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals; Risk; Tomography, X-Ray Computed; Treatment Outcome	2011
Multiple intraabdominal purulent collections demonstrated on FDG PET/CT in staging of non-Hodgkin lymphoma. Clinical nuclear medicine, 2012, Volume: 37, Issue:2 Topics: Abdomen; Edema; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiography, Abdominal; Tomography, X-Ray Computed	2012
Pediatric nonlymphoblastic non-Hodgkin lymphoma: baseline, interim, and posttreatment PET/CT versus contrast-enhanced CT for evaluation--a prospective study. Radiology, 2012, Volume: 262, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Contrast Media; Diatrizoate; Female; Fluorodeoxyglucose F18; Humans; Iopamidol; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome	2012
[Positron emission tomography with 18F-FDG compared with proliferative activity of tumor cells in different subtypes of non-Hodgkin lymphoma]. Voprosy onkologii, 2011, Volume: 57, Issue:6 Topics: Adult; Aged; Biomarkers, Tumor; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Linear Models; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Radiopharmaceuticals	2011
18F-FDG avid in uterine leiomyoma: a case report. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2012, Volume: 95, Issue:2 Topics: Adult; Comorbidity; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Leiomyoma; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Neoplasms	2012
Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET. International journal of radiation oncology, biology, physics, 2012, Aug-01, Volume: 83, Issue:5 Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Rituximab; Treatment Failure; Vincristine; Young Adult	2012
Peritoneal lymphomatosis found on 18F-FDG PET/CT. European journal of haematology, 2012, Volume: 89, Issue:6 Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Multimodal Imaging; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2012
SUV on dual-phase FDG PET/CT correlates with the Ki-67 proliferation index in patients with newly diagnosed non-Hodgkin lymphoma. Clinical nuclear medicine, 2012, Volume: 37, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed	2012
Prognostic value of quantitative parameters derived on initial staging 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with high-grade non-Hodgkin's lymphoma. Nuclear medicine communications, 2012, Volume: 33, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed; Young Adult	2012
Comparison of various criteria in interpreting end of therapy F-18 labeled fluorodeoxyglucose positron emission tomography/computed tomography in patients with aggressive non-Hodgkin lymphoma. Leukemia & lymphoma, 2013, Volume: 54, Issue:4 Topics: Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed	2013
Recurrent lymphoma in the thyroid gland detected by fluorine-18-fluorodeoxyglucose PET/CT. Endocrine, 2013, Volume: 43, Issue:1 Topics: Biopsy, Fine-Needle; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule; Tomography, X-Ray Computed	2013
Response assessment in lymphoma: time to lower the bar? Leukemia & lymphoma, 2013, Volume: 54, Issue:4 Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Multimodal Imaging; Positron-Emission Tomography; Tomography, Emission-Computed; Tomography, X-Ray Computed	2013
Value of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scan versus diagnostic contrast computed tomography in initial staging of pediatric patients with lymphoma. Leukemia & lymphoma, 2013, Volume: 54, Issue:4 Topics: Adolescent; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult	2013
Primary gastric lymphoma: utility of 18F-fluorodeoxyglucose positron emission tomography-computed tomography for detecting relapse after treatment. Leukemia & lymphoma, 2013, Volume: 54, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Reproducibility of Results; Retrospective Studies; Stomach Neoplasms; Tomography, X-Ray Computed; Young Adult	2013
The incidence of secondary central nervous system involvement in patients with non-Hodgkin's lymphoma as detected by 18F-FDG PET/CT. Nuclear medicine communications, 2013, Volume: 34, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Central Nervous System Diseases; Child; Female; Fluorodeoxyglucose F18; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult	2013
Abdominal aortic aneurysm with bony erosion mimicking recurrent non-Hodgkin lymphoma on FDG PET/CT. Clinical nuclear medicine, 2013, Volume: 38, Issue:5 Topics: Aged, 80 and over; Aortic Aneurysm, Abdominal; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed	2013
18F-FDG uptake in primary gastric malignant lymphoma correlates with glucose transporter 1 expression and histologic malignant potential. International journal of hematology, 2013, Volume: 97, Issue:1 Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastroscopy; Glucose Transporter Type 1; Glucose Transporter Type 3; Hexokinase; Humans; Ki-67 Antigen; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed	2013
SUVmax/THKmax as a biomarker for distinguishing advanced gastric carcinoma from primary gastric lymphoma. PloS one, 2012, Volume: 7, Issue:12 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gastric Mucosa; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed; Young Adult	2012
Spinal cord involvement secondary to non-Hodgkin's lymphoma identified by ¹⁸F-FDG PET/CT. Revista espanola de medicina nuclear e imagen molecular, 2013, Volume: 32, Issue:2 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Cord Neoplasms; Tomography, X-Ray Computed	2013
18F-FDG PET is an independent outcome predictor in primary central nervous system lymphoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Brain; Central Nervous System Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Genetic Markers; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Proportional Hazards Models; Regression Analysis; Retrospective Studies; Risk; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2013
The role of FDG-PET scanning in assessing lymphoma in 2012. Diagnostic and interventional imaging, 2013, Volume: 94, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; France; Hodgkin Disease; Humans; Immunotherapy; Lymphoma; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome	2013
Rare lymphoid malignancies of the breast: report of two cases illustrating potential diagnostic techniques. Journal of radiology case reports, 2012, Volume: 6, Issue:12 Topics: Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Mammography; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Mammary	2012
PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2002, Volume: 43, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed; Treatment Outcome	2002
Assessment of Lymphoma Therapy Using (18)F-FDG PET. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2002, Volume: 43, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed	2002
Thyroid nodule mimicking cervical adenopathy on FDG positron emission tomographic imaging. Clinical nuclear medicine, 2002, Volume: 27, Issue:9 Topics: Adult; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Radiography; Radiopharmaceuticals; Thyroid Nodule; Tomography, Emission-Computed	2002
[(18)F]FDG in childhood lymphoma: clinical utility and impact on management. European journal of nuclear medicine and molecular imaging, 2002, Volume: 29, Issue:9 Topics: Adult; Age Factors; Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed	2002
Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:9 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Monitoring, Physiologic; Multivariate Analysis; Neoplasm Staging; Predictive Value of Tests; Prednisolone; Probability; Prognosis; Prospective Studies; Sensitivity and Specificity; Survival Rate; Time Factors; Tomography, Emission-Computed; Treatment Outcome; Vincristine	2002
Incidental detection of primary breast carcinoma with a modified coincident camera in a patient with non-Hodgkin's lymphoma and melanoma. Clinical nuclear medicine, 2002, Volume: 27, Issue:11 Topics: Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Mastectomy, Segmental; Melanoma; Neoplasm Staging; Neoplasms, Multiple Primary; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Whole-Body Counting	2002
Utility of FDG-PET scanning in lymphoma by WHO classification. Blood, 2003, May-15, Volume: 101, Issue:10 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed	2003
Positron emission tomography in the management of lymphomas. Clinical oncology (Royal College of Radiologists (Great Britain)), 2002, Volume: 14, Issue:5 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Patient Care Planning; Radiopharmaceuticals; Tomography, Emission-Computed	2002
[FDG-PET on the day after first chemotherapy in malignant lymphoma]. Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 2002, Volume: 62, Issue:14 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Drug Monitoring; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed; Treatment Outcome	2002
Accuracy of whole-body 18F-FDP-PET for restaging malignant lymphoma. Acta medica Austriaca, 2003, Volume: 30, Issue:2 Topics: Adolescent; Adult; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Tissue Distribution; Tomography, Emission-Computed	2003
Frequent impact of [18F]fluorodeoxyglucose positron emission tomography on the staging and management of patients with indolent non-Hodgkin's lymphoma. Clinical lymphoma, 2003, Volume: 4, Issue:1 Topics: False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed	2003
Positron emission tomography in the management of patients with indolent non-Hodgkin's lymphoma. Clinical lymphoma, 2003, Volume: 4, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed	2003
Early restaging positron emission tomography with 18F-fluorodeoxyglucose in aggressive non-Hodgkin's lymphomas: is it too easy to be true? Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed; Treatment Outcome	2003
[Evaluation of lesions of malignant lymphoma using histograms of regional SUV]. Kaku igaku. The Japanese journal of nuclear medicine, 2003, Volume: 40, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed	2003
[18F]5-fluoro-2-deoxyuridine-PET for imaging of malignant tumors and for measuring tissue proliferation. Cancer biotherapy & radiopharmaceuticals, 2003, Volume: 18, Issue:3 Topics: Adult; Aged; Bone and Bones; Cell Division; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Ki-67 Antigen; Kidney; Liver; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Neoplasms; Prospective Studies; Radiopharmaceuticals; Sarcoma; Tissue Distribution; Tomography, Emission-Computed; Urinary Bladder	2003
FDG PET in the follow-up management of patients with newly diagnosed Hodgkin and non-Hodgkin lymphoma after first-line chemotherapy. International journal of radiation oncology, biology, physics, 2003, Oct-01, Volume: 57, Issue:2 Topics: Adolescent; Adult; Aged; Child; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, Emission-Computed	2003
Potential false-positive FDG PET imaging caused by subcutaneous radiotracer infiltration. Clinical nuclear medicine, 2003, Volume: 28, Issue:9 Topics: Axilla; Extravasation of Diagnostic and Therapeutic Materials; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed	2003
Pelvic anatomic localization using ureteral activity on FDG positron emission tomography. Clinical nuclear medicine, 2003, Volume: 28, Issue:10 Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Ilium; Image Enhancement; Lymphoma, Non-Hodgkin; Pelvis; Peritoneum; Radiopharmaceuticals; Subtraction Technique; Tomography, Emission-Computed; Ureter	2003
Skeletal muscle uptake detected on FDG PET 48 hours after exertion. Clinical nuclear medicine, 2003, Volume: 28, Issue:10 Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Muscle, Skeletal; Physical Exertion; Radiopharmaceuticals; Shoulder; Tomography, Emission-Computed	2003
PET imaging of Rosai-Dorfman disease: correlation with histopathology and ex-vivo beta-imaging. Archives of dermatological research, 2003, Volume: 295, Issue:7 Topics: Aged; Beta Particles; Diagnosis, Differential; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Histiocytosis, Sinus; Humans; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed	2003
18FDG positron emission tomography versus 67Ga scintigraphy as prognostic test during chemotherapy for non-Hodgkin's lymphoma. British journal of haematology, 2003, Volume: 123, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Prospective Studies; Radiopharmaceuticals; Remission Induction; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vincristine	2003
Fluorodeoxyglucose positron emission tomography in the presence of cardiac metastases. Clinical nuclear medicine, 2003, Volume: 28, Issue:12 Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Incidental Findings; Lymphoma, Non-Hodgkin; Male; Melanoma; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed; Whole-Body Counting	2003
The use of positron emission tomography with [18F] 2-fluoro-D-2-deoxyglucose (FDG-PET) in Hodgkin and non-Hodgkin's lymphoma. Hematology (Amsterdam, Netherlands), 2003, Volume: 8, Issue:6 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals	2003
[18FDG PET in the management of malignant lymphoma]. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2003, Volume: 25, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed	2003
FDG PET utility in paraneoplastic sweet syndrome. Clinical nuclear medicine, 2004, Volume: 29, Issue:2 Topics: Adult; Arthralgia; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Paraneoplastic Syndromes; Radiopharmaceuticals; Sweet Syndrome; Tomography, Emission-Computed	2004
PET scan evaluation of thymic mass after autologous peripheral blood stem-cell transplantation in an adult with non-Hodgkin's lymphoma. Leukemia & lymphoma, 2003, Volume: 44, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Peripheral Blood Stem Cell Transplantation; Radiopharmaceuticals; Thymus Hyperplasia; Tomography, Emission-Computed; Transplantation, Autologous	2003
[The clinical application of 18F-fluorodeoxyglucose coincidence imaging in lymphoma]. Zhonghua nei ke za zhi, 2004, Volume: 43, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Magnetic Resonance Angiography; Male; Middle Aged; Phantoms, Imaging; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed	2004
Atypical thoracic and supraclavicular FDG-uptake in patients with Hodgkin's and non-Hodgkin's lymphoma. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2004, Volume: 48, Issue:1 Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neck; Radiopharmaceuticals; Thorax; Tomography, Emission-Computed	2004
Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT? Radiology, 2004, Volume: 232, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed	2004
F-18 fluorodeoxyglucose positron emission tomographic imaging of cytomegalovirus pneumonia. Clinical nuclear medicine, 2004, Volume: 29, Issue:9 Topics: Aged; Cytomegalovirus Infections; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung; Lymphoma, Non-Hodgkin; Male; Pneumonia, Viral; Positron-Emission Tomography; Radiography; Radiopharmaceuticals	2004
18F-FDG PET in children with lymphomas. European journal of nuclear medicine and molecular imaging, 2005, Volume: 32, Issue:1 Topics: Adolescent; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome	2005
18F-FDG PET early after radiotherapy in lymphoma patients. Cancer biotherapy & radiopharmaceuticals, 2004, Volume: 19, Issue:5 Topics: Adult; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Inflammation; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2004
Staging in childhood lymphoma: differences between FDG-PET and CT. Nuklearmedizin. Nuclear medicine, 2005, Volume: 44, Issue:1 Topics: Adolescent; Adult; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed	2005
Use of 18F-FDG positron emission tomography following allogeneic transplantation to guide adoptive immunotherapy with donor lymphocyte infusions. British journal of haematology, 2005, Volume: 128, Issue:6 Topics: Adult; Biopsy; Bone Marrow Transplantation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Immunotherapy, Adoptive; Lymphocyte Transfusion; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Transplantation, Homologous	2005
18F-FDG PET in malignant lymphoma: significance of positive findings. European journal of nuclear medicine and molecular imaging, 2005, Volume: 32, Issue:7 Topics: Adolescent; Adult; Aged; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Time Factors; Treatment Outcome	2005
Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Jul-20, Volume: 23, Issue:21 Topics: Adult; Aged; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome	2005
Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Jul-20, Volume: 23, Issue:21 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals	2005
Computed tomography and 18F-FDG positron emission tomography for therapy control of Hodgkin's and non-Hodgkin's lymphoma patients: when do we really need FDG-PET? Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome	2005
FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Survival Analysis	2005
Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era? Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed	2006
A Bayesian approach to a patient with a residual mass after treatment for non-Hodgkin's lymphoma of the thyroid. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neck; Neoplasm, Residual; Positron-Emission Tomography; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Thyroid Neoplasms; Vincristine	2005
Unilateral testicular relapse of abdominal non-Hodgkin lymphoma detected by FDG-PET. Pediatric radiology, 2006, Volume: 36, Issue:3 Topics: Child; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Radiopharmaceuticals; Testis; Tomography, Emission-Computed	2006
Lymphomatous involvement of gastrointestinal tract: evaluation by positron emission tomography with (18)F-fluorodeoxyglucose. World journal of gastroenterology, 2005, Dec-14, Volume: 11, Issue:46 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed	2005
Usefulness of FDG-PET imaging for the radiotherapy treatment planning of pyothorax-associated lymphoma. Annals of nuclear medicine, 2005, Volume: 19, Issue:8 Topics: Aged; Empyema, Pleural; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Pleural Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Computer-Assisted; Treatment Outcome	2005
Scintigraphic appearance of "linitis plastica" in a patient with gastric non-Hodgkin's lymphoma on 18F-FDG imaging. European journal of nuclear medicine and molecular imaging, 2006, Volume: 33, Issue:5 Topics: Adult; Fluorodeoxyglucose F18; Humans; Linitis Plastica; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms	2006
A case of non-hodgkin's lymphoma of the ovary: usefulness of 18F-FDG PET for staging and assessment of the therapeutic response. Annals of nuclear medicine, 2006, Volume: 20, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Treatment Outcome; Vincristine	2006
F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas. Pediatric radiology, 2006, Volume: 36, Issue:6 Topics: Adolescent; Adult; Biopsy; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging	2006
Commentary: PET poised to alter the current paradigm for response assessment of non-Hodgkin's lymphoma. The British journal of radiology, 2006, Volume: 79, Issue:941 Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Practice Guidelines as Topic; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome	2006
Multiagency effort to focus on PET as biomarker. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006, Volume: 47, Issue:4 Topics: Biomarkers, Tumor; Cooperative Behavior; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neoplasms; Positron-Emission Tomography; Radioimmunotherapy; Radiopharmaceuticals; United States; United States Dept. of Health and Human Services	2006
Detection of widespread neurolymphomatosis with 18F-FDG PET. European journal of nuclear medicine and molecular imaging, 2006, Volume: 33, Issue:8 Topics: Adult; Cranial Nerve Diseases; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Diseases; Whole Body Imaging	2006
(18)F-FDG PET and conventional imaging for assessment of Hodgkin's disease and non Hodgkin's lymphoma. An analysis of 193 patient studies. Nuklearmedizin. Nuclear medicine, 2006, Volume: 45, Issue:3 Topics: Adult; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome	2006
Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas. Cancer, 2006, Jul-01, Volume: 107, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity	2006
Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation. Bone marrow transplantation, 2006, Volume: 38, Issue:3 Topics: Adult; Aged; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Treatment Outcome	2006
Utility of FDG-PET/CT in follow-up of children treated for Hodgkin and non-Hodgkin lymphoma. Journal of pediatric hematology/oncology, 2006, Volume: 28, Issue:5 Topics: Adolescent; Child; Child, Preschool; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity	2006
Deep venous thrombosis on F-18 FDG PET/CT imaging. Clinical nuclear medicine, 2006, Volume: 31, Issue:7 Topics: Aged; Femoral Vein; Fluorodeoxyglucose F18; Humans; Iliac Vein; Lymphoma, Non-Hodgkin; Male; Melanoma; Neoplasm Staging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Thrombophlebitis; Tomography, X-Ray Computed	2006
Diagnostic role of 18F-FDG PET in gastric MALT lymphoma. Nuclear medicine review. Central & Eastern Europe, 2006, Volume: 9, Issue:1 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Remission Induction; Retrospective Studies; Stomach Neoplasms; Time Factors	2006
Late clinically silent perforation of intestinal non-Hodgkin's lymphoma. Clinical lymphoma & myeloma, 2006, Volume: 6, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Intestinal Perforation; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome	2006
Assessing the use of FDG-PET in the detection of regional and metastatic nodes in alveolar rhabdomyosarcoma of extremities. Journal of pediatric hematology/oncology, 2006, Volume: 28, Issue:7 Topics: Child, Preschool; Extremities; Fatal Outcome; Female; Fluorodeoxyglucose F18; Groin; Hand; Humans; Infant; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Prognosis; Remission Induction; Rhabdomyosarcoma, Alveolar; Soft Tissue Neoplasms; Survival Rate; Thigh; Tomography, X-Ray Computed; Treatment Outcome	2006
FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin's lymphoma and Hodgkin's disease. Annals of hematology, 2006, Volume: 85, Issue:11 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Tomography, Emission-Computed	2006
Diagnosis of neurolymphomatosis with FDG PET. Neurology, 2006, Aug-22, Volume: 67, Issue:4 Topics: Cervical Vertebrae; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals	2006
Positron emission tomography in the detection and staging of ocular adnexal lymphoproliferative disease. Ophthalmology, 2006, Volume: 113, Issue:12 Topics: Adult; Aged; Conjunctival Neoplasms; Eye Neoplasms; Eyelid Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lacrimal Apparatus Diseases; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Orbital Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed	2006
PET/CT in lymphoma: prospective study of enhanced full-dose PET/CT versus unenhanced low-dose PET/CT. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006, Volume: 47, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiation Dosage; Radiography, Abdominal; Sclerosis; Tomography, X-Ray Computed	2006
Positron emission tomography/computed tomography: diagnostic accuracy in lymphoma. British journal of haematology, 2006, Volume: 135, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Bone Marrow; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome	2006
18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma. Leukemia & lymphoma, 2006, Volume: 47, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies	2006
18F-fluorodeoxyglucose-avid thyroid incidentalomas in patients with lymphoma. The Israel Medical Association journal : IMAJ, 2006, Volume: 8, Issue:10 Topics: Biopsy, Fine-Needle; Carcinoma, Papillary; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Ultrasonography	2006
Hodgkin's and non-Hodgkin's lymphomas. Radiologic clinics of North America, 2007, Volume: 45, Issue:1 Topics: Age Factors; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Child; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Remission Induction; Rituximab; Tomography, X-Ray Computed; Treatment Outcome	2007
Revised response criteria for malignant lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Feb-10, Volume: 25, Issue:5 Topics: Clinical Trials as Topic; Endpoint Determination; Flow Cytometry; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Interpretation, Computer-Assisted; Immunohistochemistry; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Radiopharmaceuticals; Survival Analysis; Terminology as Topic; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2007
FDG-PET lymphoma demonstration project invitational workshop. Academic radiology, 2007, Volume: 14, Issue:3 Topics: Clinical Trials, Phase II as Topic; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Quality Assurance, Health Care; Reproducibility of Results	2007
Non-Hodgkin's lymphoma of the bone can mimic osteomyelitis on FDG PET. Clinical nuclear medicine, 2007, Volume: 32, Issue:3 Topics: Adult; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Osteomyelitis; Radiopharmaceuticals; Recurrence; Tibia; Tomography, Emission-Computed	2007
Comparison of (18)F Flurodeoxyglucose PET with Ga-67 scintigraphy and conventional imaging modalities in pediatric lymphoma. Leukemia & lymphoma, 2007, Volume: 48, Issue:4 Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radionuclide Imaging; Tomography, X-Ray Computed	2007
Prospective study of 18F-FDG PET in pediatric mediastinal lymphoma: a single center experience. Leukemia & lymphoma, 2007, Volume: 48, Issue:4 Topics: Adolescent; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Positron-Emission Tomography; Prospective Studies; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2007
False-positive FDG-PET findings due to bone metastasis from prostate cancer in staging of non-Hodgkin's lymphoma. European journal of haematology, 2007, Volume: 79, Issue:1 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Prostatic Neoplasms; Rituximab; Vincristine	2007
Sarcoid-like reaction in the spleen following chemotherapy for non-Hodgkin's lymphoma. Clinical nuclear medicine, 2007, Volume: 32, Issue:7 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Diseases; Lymphoma, Non-Hodgkin; Middle Aged; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Rituximab; Sarcoidosis; Spleen; Tomography, X-Ray Computed; Vincristine	2007
The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organization c Cancer, 2007, Aug-01, Volume: 110, Issue:3 Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; World Health Organization	2007
[18F]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography for early evaluation of treatment efficacy in advanced non-Hodgkin lymphoma of uterine corpus: a case report. Clinical lymphoma & myeloma, 2007, Volume: 7, Issue:6 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Methylprednisolone; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Rituximab; Treatment Outcome; Uterine Neoplasms; Vincristine	2007
Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: whole-body MRI, PET/CT and bone marrow biopsy. European journal of radiology, 2008, Volume: 66, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Prednisone; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vincristine; Whole Body Imaging	2008
Sciatic nerve neurolymphomatosis - extent and therapy response assessment with PET/CT. Clinical nuclear medicine, 2007, Volume: 32, Issue:8 Topics: Antineoplastic Agents; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sciatic Neuropathy; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging	2007
Aggressive and indolent non-Hodgkin's lymphoma: response assessment by integrated international workshop criteria. Leukemia & lymphoma, 2007, Volume: 48, Issue:8 Topics: Adolescent; Adult; Aged; Burkitt Lymphoma; Fluorodeoxyglucose F18; Humans; International Cooperation; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Practice Guidelines as Topic; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome	2007
Therapeutic evaluation and prognostic value of interim hybrid PET/CT with (18)F-FDG after three to four cycles of chemotherapy in non-Hodgkin's lymphoma. Hematology (Amsterdam, Netherlands), 2007, Volume: 12, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Survival Analysis; Tomography, Emission-Computed	2007
18F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patients. Nuclear medicine communications, 2007, Volume: 28, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Central Nervous System Neoplasms; Cohort Studies; Female; Fluorodeoxyglucose F18; HIV Seronegativity; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Rituximab	2007
18F-FDG PET in non-Hodgkin's lymphoma: qualitative or quantitative? Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2007, Volume: 48, Issue:10 Topics: Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiopharmaceuticals	2007
Multimodality imaging of direct ureteric involvement in non-Hodgkin's lymphoma using PET/CT, CT urography and antegrade CT pyelography. The British journal of radiology, 2007, Volume: 80, Issue:959 Topics: Adult; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Ureteral Neoplasms; Urography	2007
PET versus PET-CT in patient with suspicion of non-Hodgkin lymphoma recurrence. Clinical nuclear medicine, 2007, Volume: 32, Issue:12 Topics: Aneurysm, Infected; Aneurysm, Ruptured; Aortic Aneurysm, Abdominal; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed	2007
Staging, response to therapy, and restaging of lymphomas with 18F-FDG PET. Archives of medical research, 2008, Volume: 39, Issue:1 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome	2008
Unsuspected synchronous lung cancer unveiled on FDG PET after chemotherapy for non-Hodgkin lymphoma. Clinical nuclear medicine, 2008, Volume: 33, Issue:2 Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals	2008
Non-Hodgkin lymphoma: retrospective study on the cost-effectiveness of early treatment response assessment by FDG-PET. European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Belgium; Cost-Benefit Analysis; Cyclophosphamide; Doxorubicin; Europe; Female; Fluorodeoxyglucose F18; Health Care Costs; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Radionuclide Imaging; Radiopharmaceuticals; Vincristine	2008
FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2008, Volume: 52, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy, Needle; Bone Marrow; Bone Marrow Neoplasms; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity	2008
Restaging of patients with lymphoma. Comparison of low dose CT (20 mAs) with contrast enhanced diagnostic CT in combined [18F]-FDG PET/CT. Nuklearmedizin. Nuclear medicine, 2008, Volume: 47, Issue:1 Topics: Aorta, Abdominal; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2008
Elucidation of acute renal failure due to recurrent non-Hodgkin lymphoma by F-18 FDG PET/CT. Clinical nuclear medicine, 2008, Volume: 33, Issue:3 Topics: Acute Kidney Injury; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Radiopharmaceuticals; Recurrence; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging	2008
Early prediction of response to therapy: the clinical implications in Hodgkin's and non-Hodgkin's lymphoma. European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:8 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome	2008
FDG-PET in prediction of splenectomy findings in patients with known or suspected lymphoma. Leukemia & lymphoma, 2008, Volume: 49, Issue:4 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Spleen; Splenectomy	2008
Pre-transplant 18FDG-PET predicts outcome in lymphoma patients treated with high-dose sequential chemotherapy followed by autologous stem cell transplantation. Leukemia & lymphoma, 2008, Volume: 49, Issue:4 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Positron-Emission Tomography; Preoperative Care; Prognosis; Recurrence; Retrospective Studies; Survival Rate; Transplantation, Autologous	2008
Role of whole-body [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma. La Radiologia medica, 2008, Volume: 113, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2008
Predicting malignancy grade with PET in non-Hodgkin's lymphoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1995, Volume: 36, Issue:10 Topics: Adult; Aged; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Predictive Value of Tests; Tomography, Emission-Computed	1995
Increased glucose metabolism in untreated non-Hodgkin's lymphoma: a study with positron emission tomography and fluorine-18-fluorodeoxyglucose. Blood, 1995, Nov-01, Volume: 86, Issue:9 Topics: Adult; Aged; Cell Division; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Tomography, Emission-Computed	1995
Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas. European journal of nuclear medicine, 1995, Volume: 22, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxyglucose; Drug Resistance, Multiple; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm, Residual; Oxygen Radioisotopes; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Time Factors; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Water	1995
FDG-PET for predicting the prognosis of malignant lymphoma. Annals of nuclear medicine, 1994, Volume: 8, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Middle Aged; Prognosis; Proportional Hazards Models; Survival Rate; Tomography, Emission-Computed	1994
FDG-PET for the evaluation of tumor viability after anticancer therapy. Annals of nuclear medicine, 1994, Volume: 8, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms; Radiotherapy, High-Energy; Tomography, Emission-Computed	1994
Fluorodeoxyglucose PET of abdominal and pelvic neoplasms: potential role in oncologic imaging. Radiographics : a review publication of the Radiological Society of North America, Inc, 1993, Volume: 13, Issue:5 Topics: Abdominal Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Hemangioma, Cavernous; Humans; Liver Neoplasms; Lymphoma, Non-Hodgkin; Pelvic Neoplasms; Tomography, Emission-Computed	1993
Early response monitoring in malignant lymphoma using fluorine-18 fluorodeoxyglucose single-photon emission tomography. European journal of nuclear medicine, 1993, Volume: 20, Issue:12 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxyglucose; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Monitoring, Physiologic; Prednisone; Time Factors; Tomography, Emission-Computed, Single-Photon; Vincristine	1993
Somatostatin receptor scintigraphy in malignant lymphoma: first results and comparison with glucose metabolism measured by positron-emission tomography. Hormone and metabolic research. Supplement series, 1993, Volume: 27 Topics: Adult; Biomarkers, Tumor; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Granuloma; Hodgkin Disease; Humans; Hyperplasia; Indium Radioisotopes; Lymph Nodes; Lymphoma; Lymphoma, Non-Hodgkin; Male; Octreotide; Pentetic Acid; Plasmacytoma; Receptors, Somatostatin; Tomography, Emission-Computed	1993
Early treatment response in malignant lymphoma, as determined by planar fluorine-18-fluorodeoxyglucose scintigraphy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1993, Volume: 34, Issue:10 Topics: Deoxyglucose; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Remission Induction; Tomography, Emission-Computed, Single-Photon	1993
Lactic acidosis and hypoglycemia in a patient with high-grade non-Hodgkin's lymphoma and elevated circulating TNF-alpha. Annals of hematology, 1996, Volume: 72, Issue:2 Topics: Acidosis, Lactic; Aged; Deoxyglucose; Fatal Outcome; Female; Fluorodeoxyglucose F18; Gastrointestinal Hemorrhage; Humans; Hypoglycemia; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Neoplasm Proteins; Pelvic Neoplasms; Tomography, Emission-Computed; Tumor Necrosis Factor-alpha	1996
The use of PET-18FDG imaging in the clinical evaluation of head and neck lymphoma. Clinical oncology (Royal College of Radiologists (Great Britain)), 1996, Volume: 8, Issue:1 Topics: Adult; Aged; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hyperplasia; Lymph Nodes; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed	1996
Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997, Volume: 38, Issue:3 Topics: Adolescent; Adult; Aged; Algorithms; Biopsy; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Health Care Costs; Hodgkin Disease; Humans; Image Processing, Computer-Assisted; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Tomography, Emission-Computed	1997
Primary muscle lymphoma: clinical and imaging findings. Radiology, 1997, Volume: 203, Issue:1 Topics: Adolescent; Adult; Aged; Bone and Bones; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Muscle Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed	1997
[Positron emission tomography (PET) in diagnosis and therapy planning of malignant lymphoma]. Der Radiologe, 1997, Volume: 37, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Glucose; Combined Modality Therapy; Deoxyglucose; Energy Metabolism; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Tomography, Emission-Computed; Treatment Outcome	1997
Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging. Radiology, 1997, Volume: 203, Issue:3 Topics: Adolescent; Adult; Aged; Biopsy; Child; Contrast Media; Deoxyglucose; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Iodine Radioisotopes; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiographic Image Enhancement; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting	1997
[Comparison of findings with 18-FDG PET and CT in pretherapeutic staging of malignant lymphoma]. Nuklearmedizin. Nuclear medicine, 1997, Volume: 36, Issue:7 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Staging; Radiopharmaceuticals; Recurrence; Regression Analysis; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed	1997
Extranodal malignant lymphoma: detection with FDG PET versus CT. Radiology, 1998, Volume: 206, Issue:2 Topics: Adult; Biopsy; False Negative Reactions; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed	1998
18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:2 Topics: Adolescent; Adult; Aged; Biopsy, Needle; Bone Marrow; Child; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed	1998
Usefulness of FDG-PET in diagnosing primary lymphoma of the liver. International journal of hematology, 1997, Volume: 66, Issue:4 Topics: Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphoma, Non-Hodgkin; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed	1997
Detection of unsuspected recurrent lymphoma with fluorodeoxyglucose-positron emission tomographic imaging after induction chemotherapy: a case study. American journal of clinical oncology, 1998, Volume: 21, Issue:2 Topics: Adult; Antineoplastic Agents; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed	1998
Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose. Blood, 1998, Jun-15, Volume: 91, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Monitoring; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome	1998
[Computerized tomography and F-18-FDG positron emission tomography in staging of malignant lymphomas: a comparison]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1998, Volume: 168, Issue:5 Topics: Adolescent; Adult; Age Factors; Aged; Child; Child, Preschool; Evaluation Studies as Topic; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Recurrence; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed	1998
Computed tomography, magnetic resonance imaging and positron emission tomography in non-Hodgkin's lymphoma. Acta radiologica. Supplementum, 1998, Volume: 417 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Forecasting; Gastroscopy; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Methionine; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Prognosis; Radiopharmaceuticals; Remission Induction; Stomach Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed	1998
Images in cardiovascular medicine. Metabolic imaging identifies non-Hodgkin's lymphoma infiltrating heart. Circulation, 1998, Jun-30, Volume: 97, Issue:25 Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Myocardium; Radiopharmaceuticals; Tomography, Emission-Computed	1998
F-18-FDG uptake in tuberculosis. Clinical nuclear medicine, 1998, Volume: 23, Issue:11 Topics: Adult; Breast Neoplasms; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Paget's Disease, Mammary; Radionuclide Imaging; Radiopharmaceuticals; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary	1998
Positron emission tomography with 18F-FDG to detect residual disease after therapy for malignant lymphoma. Nuclear medicine communications, 1998, Volume: 19, Issue:11 Topics: Adolescent; Adult; Aged; Blood Glucose; Body Surface Area; Body Weight; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm, Residual; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed	1998
Role of attenuation correction for fluorine-18 fluorodeoxyglucose positron emission tomography in the primary staging of malignant lymphoma. European journal of nuclear medicine, 1999, Volume: 26, Issue:1 Topics: Adolescent; Adult; Child; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Processing, Computer-Assisted; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed	1999
Whole-body 18F-FDG PET for the evaluation of patients with Hodgkin's disease and non-Hodgkin's lymphoma. Nuclear medicine communications, 1999, Volume: 20, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Marrow; Digestive System; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Liver; Lymph Nodes; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Spleen; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting	1999
[Clinical value of FDG PET for therapy monitoring of malignant lymphoma--results of a retrospective study in 72 patients]. Nuklearmedizin. Nuclear medicine, 1999, Volume: 38, Issue:1 Topics: Adolescent; Adult; Aged; Biopsy; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; L-Lactate Dehydrogenase; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Monitoring, Physiologic; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed	1999
Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood, 1999, Jul-15, Volume: 94, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Diagnosis, Differential; Disease-Free Survival; Female; Fibrosis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Life Tables; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm, Residual; Predictive Value of Tests; Prognosis; Survival Analysis; Tissue Distribution; Tomography, Emission-Computed; Tomography, X-Ray Computed	1999
Correlation of CT-guided fine-needle aspiration biopsy of the liver with fluoride-18 fluorodeoxyglucose positron emission tomography in the assessment of metastatic hepatic abnormalities. Diagnostic cytopathology, 1999, Volume: 21, Issue:1 Topics: Biopsy, Needle; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Liver; Liver Neoplasms; Lymphoma, Non-Hodgkin; Melanoma; Tomography, Emission-Computed	1999
Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study. British journal of cancer, 1999, Volume: 80, Issue:3-4 Topics: Adult; Aged; Blood Glucose; Fatty Acids, Nonesterified; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Hodgkin Disease; Humans; Lipolysis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myocardium; Radiopharmaceuticals; Tomography, Emission-Computed	1999
[Granulation tissue: pitfall in therapy control with F-18-FDG PET after chemotherapy]. Nuklearmedizin. Nuclear medicine, 1999, Volume: 38, Issue:8 Topics: Abdominal Neoplasms; Diagnostic Errors; False Positive Reactions; Fluorodeoxyglucose F18; Granulocytes; Humans; Lymphoma, Non-Hodgkin; Macrophages; Male; Middle Aged; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed; Tomography, X-Ray Computed	1999
18-FDG-PET for the assessment of residual masses on CT following treatment of lymphomas. Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11 Suppl 1 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm, Residual; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed	2000
Positron emission tomography for detection and staging of malignant lymphoma. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 2000, Volume: 156 Topics: Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Tomography, Emission-Computed; Tomography, X-Ray Computed	2000
FDG positron emission tomography in lymphoma. Tecnologica. MAP supplement. Blue Cross and Blue Shield Association. Medical Advisory Panel, 2000 Topics: Blue Cross Blue Shield Insurance Plans; Device Approval; Drug Approval; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Outcome Assessment, Health Care; Radiopharmaceuticals; Technology Assessment, Biomedical; Tomography, Emission-Computed; United States; United States Food and Drug Administration	2000
Metabolic response of non-Hodgkin's lymphoma to 131I-anti-B1 radioimmunotherapy: evaluation with FDG PET. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2000, Volume: 41, Issue:6 Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphoma, Non-Hodgkin; Radioimmunotherapy; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, Emission-Computed	2000
Persistent tumor 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin's lymphoma. Haematologica, 2000, Volume: 85, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed; Treatment Outcome	2000
The impact of FDG positron emission tomography imaging on the management of lymphomas. The British journal of radiology, 2000, Volume: 73, Issue:869 Topics: Adolescent; Adult; Aged; Contrast Media; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed	2000
Dichotomy between Tc-99m MDP bone scan and fluorine-18 fluorodeoxyglucose coincidence detection positron emission tomography in patients with non-Hodgkin's lymphoma. Clinical nuclear medicine, 2000, Volume: 25, Issue:7 Topics: Adult; Bone Marrow Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tomography, Emission-Computed	2000
Imaging of malignant lymphomas with F-18 FDG coincidence detection positron emission tomography. Clinical nuclear medicine, 2000, Volume: 25, Issue:10 Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gamma Cameras; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed	2000
[Clinical value of FDG PET using coincident gamma cameras in staging and restaging of malignant lymphoma--compared with convenitonal diagnostic methods]. Nuklearmedizin. Nuclear medicine, 2000, Volume: 39, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Predictive Value of Tests; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography	2000
Effect of N-butylscopolamine on intestinal uptake of fluorine-18-fluorodeoxyglucose in PET imaging of the abdomen. Nuklearmedizin. Nuclear medicine, 2000, Volume: 39, Issue:8 Topics: Abdomen; Adult; Blood Glucose; Butylscopolammonium Bromide; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Humans; Liver; Lymphoma; Lymphoma, Non-Hodgkin; Male; Parasympatholytics; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed	2000
Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods? Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Jan-15, Volume: 19, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm, Residual; Prognosis; Radiopharmaceuticals; Remission Induction; Survival Analysis; Tomography, Emission-Computed	2001
[Value of positron emission tomography in treatment of lymphoma patients]. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2001, Volume: 177, Issue:3 Topics: Blood Glucose; Combined Modality Therapy; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm, Residual; Sensitivity and Specificity; Survival Rate; Tomography, Emission-Computed; Treatment Outcome	2001
F-18 FDG positron emission tomography in primary breast non-Hodgkin's lymphoma. Clinical nuclear medicine, 2001, Volume: 26, Issue:4 Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed	2001
False-positive F-18 FDG gamma camera positron emission tomographic imaging resulting from inflammation of an anterior mediastinal mass in a patient with non-Hodgkin's lymphoma. Clinical nuclear medicine, 2001, Volume: 26, Issue:5 Topics: Adolescent; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lymphoma, Non-Hodgkin; Male; Mediastinal Diseases; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed	2001
Whole-body hybrid PET with 18F-FDG in the staging of non-Hodgkin's lymphoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Feasibility Studies; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gamma Cameras; Humans; Lymph Nodes; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed	2001
FDG PET imaging in patients with lymphoma: a clinical perspective. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Radiopharmaceuticals; Tomography, Emission-Computed	2001
18-FDG-PET as a prognostic indicator in the treatment of aggressive Non-Hodgkin's Lymphoma-comparison with CT. Leukemia & lymphoma, 2000, Volume: 39, Issue:5-6 Topics: Adult; Age Factors; Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Predictive Value of Tests; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Spleen; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome	2000
Similar pelvic abnormalities on FDG positron emission tomography of different origins. Clinical nuclear medicine, 2001, Volume: 26, Issue:6 Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Pelvic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed	2001
Prognostic significance of positron emission tomography using fluorine-18-fluorodeoxyglucose in patients treated for malignant lymphoma. Nuklearmedizin. Nuclear medicine, 2001, Volume: 40, Issue:1 Topics: Adolescent; Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed	2001
18F-Fluorodeoxyglucose PET in a patient with primary small bowel lymphoma: the only sensitive method of imaging. The American journal of gastroenterology, 2001, Volume: 96, Issue:8 Topics: Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Intestine, Small; Lymphoma, Non-Hodgkin; Radiopharmaceuticals; Tomography, Emission-Computed	2001
Pulmonary intravascular lymphoma complicated with Pneumocystis carinii pneumonia: a case report. Japanese journal of clinical oncology, 2001, Volume: 31, Issue:7 Topics: Aged; Dementia; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Hypoxia; Lung; Lymphoma, Non-Hodgkin; Male; Pneumonia, Pneumocystis; Radionuclide Imaging; Vascular Neoplasms	2001
Positron emission tomography (PET) for staging low-grade non-Hodgkin's lymphomas (NHL). Cancer biotherapy & radiopharmaceuticals, 2001, Volume: 16, Issue:4 Topics: Adult; Aged; Bone Marrow; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver; Lung; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Spleen; Tomography, Emission-Computed	2001
Staging and monitoring response to treatment in primary non-Hodgkin's lymphoma of bone marrow using (18)F-fluorodeoxyglucose positron emission tomography. Clinical lymphoma, 2001, Volume: 1, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Neoplasms; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome; Vincristine	2001
F-18 FDG positron emission tomography demonstrates resolution of non-Hodgkin's lymphoma of the parotid gland in a patient with Sjogren's syndrome: before and after anti-CD20 antibody rituximab therapy. Clinical nuclear medicine, 2002, Volume: 27, Issue:2 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Parotid Neoplasms; Radiopharmaceuticals; Rituximab; Sjogren's Syndrome; Tomography, Emission-Computed	2002
Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation. Leukemia, 2002, Volume: 16, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Prognosis; Radiopharmaceuticals; Survival Analysis; Survival Rate; Tomography, Emission-Computed; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation	2002
Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkin's disease and non-Hodgkin's lymphoma. British journal of haematology, 2001, Volume: 115, Issue:4 Topics: Adolescent; Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Recurrence; Tomography, Emission-Computed	2001
Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma. The American journal of medicine, 2002, Volume: 112, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed	2002
Fluorine-18 fluorodeoxyglucose positron emission tomography for lymphoma: incorporating new technology into clinical care. The American journal of medicine, 2002, Volume: 112, Issue:4 Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed	2002
FDG PET in the management of lymphoma: a clinical perspective. European journal of nuclear medicine and molecular imaging, 2002, Volume: 29, Issue:4 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasm Staging; Predictive Value of Tests; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed	2002
[Current status of nuclear medicine. Clinical application of FDG-PET for cancer diagnosis. Malignant lymphoma]. Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 2002, Volume: 62, Issue:6 Topics: Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed	2002
[Diagnosis of energy metabolism in ENT tumors--a PET study]. HNO, 1992, Volume: 40, Issue:6 Topics: Blood Glucose; Carcinoma, Squamous Cell; Deoxyglucose; Energy Metabolism; Fluorodeoxyglucose F18; Follow-Up Studies; Hemangiopericytoma; Humans; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Survival Rate; Tomography, Emission-Computed	1992
Suitability of rodent tumor models for experimental PET with L-[1-11C]tyrosine and 2-[18F]fluoro-2-deoxy-D-glucose. International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology, 1991, Volume: 18, Issue:5 Topics: Animals; Carbon Isotopes; Carcinoma 256, Walker; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Lymphoma, Non-Hodgkin; Male; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Proteins; Rats; Rats, Inbred Strains; Tissue Distribution; Tomography, Emission-Computed; Tyrosine	1991
The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1991, Volume: 32, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Tomography, Emission-Computed	1991
Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1991, Volume: 32, Issue:6 Topics: Adult; Aged; Carbon Radioisotopes; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Methionine; Middle Aged; Tomography, Emission-Computed	1991
Comparison of fluorine-18-2-fluorodeoxyglucose and gallium-67 citrate imaging for detection of lymphoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1987, Volume: 28, Issue:3 Topics: Adult; Aged; Deoxy Sugars; Deoxyglucose; Drug Evaluation; Female; Fluorine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Radioisotopes; Radionuclide Imaging; Retroperitoneal Neoplasms	1987